[10-Q] SolarEdge Technologies, Inc. Quarterly Earnings Report
Filing Impact
Filing Sentiment
Form Type
10-Q
AVITA Medical (RCEL) filed an 8-K disclosing a fifth amendment to its October 2023 credit agreement with OrbiMed. The amendment reduces the trailing-12-month revenue covenants to $73 m (Q3-25), $77 m (Q4-25), $90 m (Q1-26) and $103 m (Q2-26); the prior $115 m covenant remains in force for subsequent quarters through maturity. In exchange, the company will issue 400,000 registered common shares to the lenders. All other terms of the facility are unchanged.
The filing also notes that a press release with Q2-25 results (Ex. 99.1) was issued, but the 8-K does not include any financial figures from that release.
Key implications:
- Covenant relief provides short-term balance-sheet flexibility.
- Share issuance introduces modest dilution (鈮�1.3 % of the 30.7 m shares outstanding as of the last 10-Q, if unchanged).
- Higher revenue thresholds resume after June 2026, keeping long-term performance pressure intact.
AVITA Medical (RCEL) ha depositato un modulo 8-K comunicando una quinta modifica al suo accordo di credito di ottobre 2023 con OrbiMed. La modifica riduce i covenant sui ricavi degli ultimi 12 mesi a 73 milioni di dollari (Q3-25), 77 milioni (Q4-25), 90 milioni (Q1-26) e 103 milioni (Q2-26); il precedente covenant di 115 milioni rimane valido per i trimestri successivi fino alla scadenza. In cambio, la societ脿 emetter脿 400.000 azioni ordinarie registrate ai finanziatori. Tutti gli altri termini del finanziamento restano invariati.
Il deposito segnala inoltre che 猫 stato diffuso un comunicato stampa con i risultati del Q2-25 (Ex. 99.1), ma il modulo 8-K non include alcun dato finanziario da quel comunicato.
Implicazioni chiave:
- Il sollievo sui covenant offre una maggiore flessibilit脿 di bilancio a breve termine.
- L鈥檈missione di azioni comporta una lieve diluizione (circa l鈥�1,3% delle 30,7 milioni di azioni in circolazione secondo l鈥檜ltimo 10-Q, se invariato).
- I livelli di ricavo pi霉 elevati riprenderanno dopo giugno 2026, mantenendo intatta la pressione sulle prestazioni a lungo termine.
AVITA Medical (RCEL) present贸 un formulario 8-K revelando una quinta enmienda a su acuerdo de cr茅dito de octubre de 2023 con OrbiMed. La enmienda reduce los convenios de ingresos acumulados de 12 meses a 73 millones de d贸lares (Q3-25), 77 millones (Q4-25), 90 millones (Q1-26) y 103 millones (Q2-26); el convenio previo de 115 millones permanece vigente para los trimestres posteriores hasta el vencimiento. A cambio, la compa帽铆a emitir谩 400,000 acciones ordinarias registradas a los prestamistas. Todos los dem谩s t茅rminos de la facilidad permanecen sin cambios.
El informe tambi茅n se帽ala que se emiti贸 un comunicado de prensa con los resultados del Q2-25 (Ex. 99.1), pero el 8-K no incluye cifras financieras de ese comunicado.
Implicaciones clave:
- El alivio en los convenios proporciona flexibilidad a corto plazo en el balance.
- La emisi贸n de acciones introduce una diluci贸n modesta (鈮�1.3% de las 30.7 millones de acciones en circulaci贸n seg煤n el 煤ltimo 10-Q, si no ha cambiado).
- Los umbrales de ingresos m谩s altos se reanudan despu茅s de junio de 2026, manteniendo la presi贸n de desempe帽o a largo plazo intacta.
AVITA Medical(RCEL)電� OrbiMed鞕� 2023雲� 10鞗� 觳搓舶頃� 鞁犾毄 瓿勳暯鞐� 雽�頃� 雼れ劘 氩堨Ц 靾橃爼鞎堨潉 瓿店皽頃橂姅 8-K毳� 鞝滌稖頄堨姷雼堧嫟. 鞚措矆 靾橃爼鞎堨潃 斓滉芳 12臧滌洈 毵れ稖 臁瓣贝鞚� 7,300毵� 雼煬(Q3-25), 7,700毵� 雼煬(Q4-25), 9,000毵� 雼煬(Q1-26), 1鞏� 300毵� 雼煬(Q2-26)搿� 臧愳唽鞁滌及鞙茧┌, 鞚挫爠鞚� 1鞏� 1,500毵� 雼煬 臁瓣贝鞚� 毵岅赴旯岇 鞚错泟 攵勱赴鞐愲弰 鞙犿毃頃╇媹雼�. 鞚挫棎 雽�頃� 雽�臧�搿� 須岇偓電� 雽�於滌瀽霌れ棎瓴� 霌彪霅� 氤错喌欤� 400,000欤�毳� 氚滍枆頃╇媹雼�. 旮绊儉 鞁滌劋 臁瓣贝鞚� 氤�瓴诫悩歆� 鞎婌晿鞀惦媹雼�.
霕愴暅 鞚措矆 鞝滌稖靹滊電� Q2-25 鞁れ爜鞐� 甏�頃� 氤措弰鞛愲(Ex. 99.1)臧� 氚滍枆霅橃棃鞚岇潉 氇呾嫓頃橃毵�, 8-K鞐愲姅 頃措嫻 氤措弰鞛愲鞚� 鞛 靾橃箻臧� 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟.
欤检殧 鞁滌偓鞝�:
- 臁瓣贝 鞕勴檾搿� 雼赴 鞛 鞙犾棸靹膘澊 頇曤炒霅╇媹雼�.
- 欤检嫕 氚滍枆鞙茧 鞎疥皠鞚� 頋劃 須臣臧� 氚滌儩頃╇媹雼�(斓滉芳 10-Q 旮办 3,070毵� 欤� 欷� 鞎� 1.3%鞐� 頃措嫻, 氤�霃� 鞐嗢潉 鞁�).
- 2026雲� 6鞗� 鞚错泟鞐愲姅 雿� 雴掛潃 毵れ稖 旮办鞚� 鞛皽霅橃柎 鞛リ赴 靹标臣 鞎曤皶鞚� 鞙犾霅╇媹雼�.
AVITA Medical (RCEL) a d茅pos茅 un formulaire 8-K d茅voilant un cinqui猫me amendement 脿 son accord de cr茅dit d'octobre 2023 avec OrbiMed. L'amendement 谤茅诲耻颈迟 les engagements de chiffre d'affaires sur 12 mois glissants 脿 73 M$ (T3-25), 77 M$ (T4-25), 90 M$ (T1-26) et 103 M$ (T2-26) ; l'engagement pr茅c茅dent de 115 M$ reste en vigueur pour les trimestres suivants jusqu'脿 l'茅ch茅ance. En contrepartie, la soci茅t茅 茅mettra 400 000 actions ordinaires enregistr茅es aux pr锚teurs. Tous les autres termes de la facilit茅 restent inchang茅s.
Le d茅p么t indique 茅galement qu'un communiqu茅 de presse pr茅sentant les r茅sultats du T2-25 (Ex. 99.1) a 茅t茅 publi茅, mais le 8-K ne contient aucune donn茅e financi猫re issue de ce communiqu茅.
Principales implications :
- Le rel芒chement des engagements offre une flexibilit茅 脿 court terme au bilan.
- L'茅mission d'actions entra卯ne une dilution mod茅r茅e (鈮�1,3 % des 30,7 M d'actions en circulation selon le dernier 10-Q, si inchang茅).
- Les seuils de chiffre d'affaires plus 茅lev茅s reprendront apr猫s juin 2026, maintenant la pression sur la performance 脿 long terme.
AVITA Medical (RCEL) hat ein 8-K eingereicht, in dem eine f眉nfte 脛nderung seines Kreditvertrags vom Oktober 2023 mit OrbiMed offengelegt wird. Die 脛nderung senkt die Umsatzvorgaben der letzten 12 Monate auf 73 Mio. $ (Q3-25), 77 Mio. $ (Q4-25), 90 Mio. $ (Q1-26) und 103 Mio. $ (Q2-26); die vorherige Vorgabe von 115 Mio. $ bleibt f眉r die folgenden Quartale bis zur F盲lligkeit bestehen. Im Gegenzug wird das Unternehmen 400.000 eingetragene Stammaktien an die Kreditgeber ausgeben. Alle anderen Bedingungen der Kreditfazilit盲t bleiben unver盲ndert.
Die Einreichung weist auch darauf hin, dass eine Pressemitteilung mit den Ergebnissen f眉r Q2-25 (Ex. 99.1) ver枚ffentlicht wurde, das 8-K jedoch keine finanziellen Zahlen aus dieser Mitteilung enth盲lt.
Wesentliche Auswirkungen:
- Die Erleichterung bei den Covenants bietet kurzfristige Flexibilit盲t in der Bilanz.
- Die Aktienausgabe f眉hrt zu einer moderaten Verw盲sserung (ca. 1,3 % von 30,7 Mio. ausstehenden Aktien laut dem letzten 10-Q, sofern unver盲ndert).
- H枚here Umsatzschwellen werden nach Juni 2026 wieder eingef眉hrt, wodurch der Leistungsdruck auf lange Sicht erhalten bleibt.
Positive
- Reduced revenue covenants lower the risk of breaching credit terms through mid-2026, improving short-term financial flexibility.
- Lenders鈥� agreement to amend for a modest equity consideration (400 k shares) implies continued support rather than punitive cash fees.
Negative
- Equity issuance creates dilution and signals limited cash capacity to pay amendment fees.
- Lowered revenue thresholds may indicate management expects slower growth, and the covenant resets to $115 m after Q2-26, preserving long-term pressure.
Insights
TL;DR: Covenant resets ease near-term default risk; equity sweetener suggests lender leverage remains high.
The lowered revenue hurdles materially reduce the probability of technical default over the next 12 months, improving liquidity visibility. However, requiring 400 k shares as consideration indicates OrbiMed maintained pricing power, reflecting lender caution about RCEL鈥檚 growth trajectory. The reversion to a $115 m covenant after Q2-26 reinstates execution risk. Overall impact is moderately positive for credit profile but neutral-to-dilutive for equity.
TL;DR: Short-term breathing room gained, but revenue bar only delayed; dilution small yet signals softer outlook.
Management effectively pushed out revenue targets by 12-18 months, suggesting internal forecasts trail original plans. The 1.3 % equity issuance is minor, but granting stock rather than cash underscores capital preservation needs. Investors should watch if Q2-25 results (not included here) show momentum sufficient to bridge back to the $115 m covenant by H2-26. Absent that, further amendments鈥攐r equity鈥攎ay be required.
AVITA Medical (RCEL) ha depositato un modulo 8-K comunicando una quinta modifica al suo accordo di credito di ottobre 2023 con OrbiMed. La modifica riduce i covenant sui ricavi degli ultimi 12 mesi a 73 milioni di dollari (Q3-25), 77 milioni (Q4-25), 90 milioni (Q1-26) e 103 milioni (Q2-26); il precedente covenant di 115 milioni rimane valido per i trimestri successivi fino alla scadenza. In cambio, la societ脿 emetter脿 400.000 azioni ordinarie registrate ai finanziatori. Tutti gli altri termini del finanziamento restano invariati.
Il deposito segnala inoltre che 猫 stato diffuso un comunicato stampa con i risultati del Q2-25 (Ex. 99.1), ma il modulo 8-K non include alcun dato finanziario da quel comunicato.
Implicazioni chiave:
- Il sollievo sui covenant offre una maggiore flessibilit脿 di bilancio a breve termine.
- L鈥檈missione di azioni comporta una lieve diluizione (circa l鈥�1,3% delle 30,7 milioni di azioni in circolazione secondo l鈥檜ltimo 10-Q, se invariato).
- I livelli di ricavo pi霉 elevati riprenderanno dopo giugno 2026, mantenendo intatta la pressione sulle prestazioni a lungo termine.
AVITA Medical (RCEL) present贸 un formulario 8-K revelando una quinta enmienda a su acuerdo de cr茅dito de octubre de 2023 con OrbiMed. La enmienda reduce los convenios de ingresos acumulados de 12 meses a 73 millones de d贸lares (Q3-25), 77 millones (Q4-25), 90 millones (Q1-26) y 103 millones (Q2-26); el convenio previo de 115 millones permanece vigente para los trimestres posteriores hasta el vencimiento. A cambio, la compa帽铆a emitir谩 400,000 acciones ordinarias registradas a los prestamistas. Todos los dem谩s t茅rminos de la facilidad permanecen sin cambios.
El informe tambi茅n se帽ala que se emiti贸 un comunicado de prensa con los resultados del Q2-25 (Ex. 99.1), pero el 8-K no incluye cifras financieras de ese comunicado.
Implicaciones clave:
- El alivio en los convenios proporciona flexibilidad a corto plazo en el balance.
- La emisi贸n de acciones introduce una diluci贸n modesta (鈮�1.3% de las 30.7 millones de acciones en circulaci贸n seg煤n el 煤ltimo 10-Q, si no ha cambiado).
- Los umbrales de ingresos m谩s altos se reanudan despu茅s de junio de 2026, manteniendo la presi贸n de desempe帽o a largo plazo intacta.
AVITA Medical(RCEL)電� OrbiMed鞕� 2023雲� 10鞗� 觳搓舶頃� 鞁犾毄 瓿勳暯鞐� 雽�頃� 雼れ劘 氩堨Ц 靾橃爼鞎堨潉 瓿店皽頃橂姅 8-K毳� 鞝滌稖頄堨姷雼堧嫟. 鞚措矆 靾橃爼鞎堨潃 斓滉芳 12臧滌洈 毵れ稖 臁瓣贝鞚� 7,300毵� 雼煬(Q3-25), 7,700毵� 雼煬(Q4-25), 9,000毵� 雼煬(Q1-26), 1鞏� 300毵� 雼煬(Q2-26)搿� 臧愳唽鞁滌及鞙茧┌, 鞚挫爠鞚� 1鞏� 1,500毵� 雼煬 臁瓣贝鞚� 毵岅赴旯岇 鞚错泟 攵勱赴鞐愲弰 鞙犿毃頃╇媹雼�. 鞚挫棎 雽�頃� 雽�臧�搿� 須岇偓電� 雽�於滌瀽霌れ棎瓴� 霌彪霅� 氤错喌欤� 400,000欤�毳� 氚滍枆頃╇媹雼�. 旮绊儉 鞁滌劋 臁瓣贝鞚� 氤�瓴诫悩歆� 鞎婌晿鞀惦媹雼�.
霕愴暅 鞚措矆 鞝滌稖靹滊電� Q2-25 鞁れ爜鞐� 甏�頃� 氤措弰鞛愲(Ex. 99.1)臧� 氚滍枆霅橃棃鞚岇潉 氇呾嫓頃橃毵�, 8-K鞐愲姅 頃措嫻 氤措弰鞛愲鞚� 鞛 靾橃箻臧� 韽暔霅橃柎 鞛堨 鞎婌姷雼堧嫟.
欤检殧 鞁滌偓鞝�:
- 臁瓣贝 鞕勴檾搿� 雼赴 鞛 鞙犾棸靹膘澊 頇曤炒霅╇媹雼�.
- 欤检嫕 氚滍枆鞙茧 鞎疥皠鞚� 頋劃 須臣臧� 氚滌儩頃╇媹雼�(斓滉芳 10-Q 旮办 3,070毵� 欤� 欷� 鞎� 1.3%鞐� 頃措嫻, 氤�霃� 鞐嗢潉 鞁�).
- 2026雲� 6鞗� 鞚错泟鞐愲姅 雿� 雴掛潃 毵れ稖 旮办鞚� 鞛皽霅橃柎 鞛リ赴 靹标臣 鞎曤皶鞚� 鞙犾霅╇媹雼�.
AVITA Medical (RCEL) a d茅pos茅 un formulaire 8-K d茅voilant un cinqui猫me amendement 脿 son accord de cr茅dit d'octobre 2023 avec OrbiMed. L'amendement 谤茅诲耻颈迟 les engagements de chiffre d'affaires sur 12 mois glissants 脿 73 M$ (T3-25), 77 M$ (T4-25), 90 M$ (T1-26) et 103 M$ (T2-26) ; l'engagement pr茅c茅dent de 115 M$ reste en vigueur pour les trimestres suivants jusqu'脿 l'茅ch茅ance. En contrepartie, la soci茅t茅 茅mettra 400 000 actions ordinaires enregistr茅es aux pr锚teurs. Tous les autres termes de la facilit茅 restent inchang茅s.
Le d茅p么t indique 茅galement qu'un communiqu茅 de presse pr茅sentant les r茅sultats du T2-25 (Ex. 99.1) a 茅t茅 publi茅, mais le 8-K ne contient aucune donn茅e financi猫re issue de ce communiqu茅.
Principales implications :
- Le rel芒chement des engagements offre une flexibilit茅 脿 court terme au bilan.
- L'茅mission d'actions entra卯ne une dilution mod茅r茅e (鈮�1,3 % des 30,7 M d'actions en circulation selon le dernier 10-Q, si inchang茅).
- Les seuils de chiffre d'affaires plus 茅lev茅s reprendront apr猫s juin 2026, maintenant la pression sur la performance 脿 long terme.
AVITA Medical (RCEL) hat ein 8-K eingereicht, in dem eine f眉nfte 脛nderung seines Kreditvertrags vom Oktober 2023 mit OrbiMed offengelegt wird. Die 脛nderung senkt die Umsatzvorgaben der letzten 12 Monate auf 73 Mio. $ (Q3-25), 77 Mio. $ (Q4-25), 90 Mio. $ (Q1-26) und 103 Mio. $ (Q2-26); die vorherige Vorgabe von 115 Mio. $ bleibt f眉r die folgenden Quartale bis zur F盲lligkeit bestehen. Im Gegenzug wird das Unternehmen 400.000 eingetragene Stammaktien an die Kreditgeber ausgeben. Alle anderen Bedingungen der Kreditfazilit盲t bleiben unver盲ndert.
Die Einreichung weist auch darauf hin, dass eine Pressemitteilung mit den Ergebnissen f眉r Q2-25 (Ex. 99.1) ver枚ffentlicht wurde, das 8-K jedoch keine finanziellen Zahlen aus dieser Mitteilung enth盲lt.
Wesentliche Auswirkungen:
- Die Erleichterung bei den Covenants bietet kurzfristige Flexibilit盲t in der Bilanz.
- Die Aktienausgabe f眉hrt zu einer moderaten Verw盲sserung (ca. 1,3 % von 30,7 Mio. ausstehenden Aktien laut dem letzten 10-Q, sofern unver盲ndert).
- H枚here Umsatzschwellen werden nach Juni 2026 wieder eingef眉hrt, wodurch der Leistungsdruck auf lange Sicht erhalten bleibt.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended June 30, 2025
OR
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from _________ to __________
Commission File Number: 001-36894
|
|
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
||
|
|
||
|
(Address of Principal Executive Offices, zip code)
|
||
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
☒
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☐
|
Smaller Reporting Company
|
|
|
Emerging growth company
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☒
As of August 1, 2025, there were 59,374,793 shares of the registrant’s common stock, par value of $0.0001 per share, outstanding.
TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION | |
ITEM 1.Financial Statements | F-1 |
Condensed Consolidated Balance Sheets | F-1 |
Condensed Consolidated Statements of Income (Loss) | F-3 |
Condensed Consolidated Statements of Comprehensive Income (Loss) | F-4 |
Condensed Consolidated Statements of Stockholders’ Equity | F-5 |
Condensed Consolidated Statements of Cash Flows | F-7 |
Notes to the Condensed Consolidated Financial Statements (unaudited) | F-9 |
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 3 |
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk | 20 |
ITEM 4. Controls and Procedures | 21 |
PART II. OTHER INFORMATION | 22 |
ITEM 1. Legal Proceedings | 22 |
ITEM 1A. Risk Factors | 22 |
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds | 23 |
ITEM 3. Defaults upon Senior Securities | 23 |
ITEM 4. Mine Safety Disclosures | 23 |
ITEM 5. Other Information | 23 |
ITEM 6. Exhibits | 24 |
EXHIBIT INDEX | 24 |
2
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
SOLAREDGE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in thousands, except per share data)
|
June 30,
2025
|
December 31,
2024
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Restricted cash
|
|
|
||||||
|
Marketable securities
|
|
|
||||||
|
Trade receivables, net of allowances of $
|
|
|
||||||
|
Inventories, net
|
|
|
||||||
|
Prepaid expenses and other current assets
|
|
|
||||||
|
Total current assets
|
|
|
||||||
|
LONG-TERM ASSETS:
|
||||||||
|
Marketable securities
|
|
|
||||||
|
Property, plant and equipment, net
|
|
|
||||||
|
Operating lease right-of-use assets, net
|
|
|
||||||
|
Intangible assets, net
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Loan receivables, net
|
|
|
||||||
|
Other long-term assets
|
|
|
||||||
|
Total long-term assets
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 1
SOLAREDGE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Cont.)
(in thousands, except per share data)
|
June 30,
2025
|
December 31,
2024
|
|||||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables
|
$
|
|
$
|
|
||||
|
Employees and payroll accruals
|
|
|
||||||
|
Warranty obligations
|
|
|
||||||
|
Deferred revenues and customers advances
|
|
|
||||||
|
Accrued expenses and other current liabilities
|
|
|
||||||
|
Convertible senior notes, net
|
|
|
||||||
|
Total current liabilities
|
|
|
||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Convertible senior notes, net
|
|
|
||||||
|
Warranty obligations
|
|
|
||||||
|
Deferred revenues
|
|
|
||||||
|
Finance lease liabilities
|
|
|
||||||
|
Operating lease liabilities
|
|
|
||||||
|
Other long-term liabilities
|
|
|
||||||
|
Total long-term liabilities
|
|
|
||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
|
STOCKHOLDERS’ EQUITY:
|
||||||||
|
Common stock of $
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Treasury stock, at cost;
|
(
|
)
|
(
|
)
|
||||
|
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Total stockholders’ equity
|
|
|
||||||
|
Total liabilities and stockholders’ equity
|
$
|
|
$
|
|
||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 2
SOLAREDGE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF LOSS (Unaudited)
(in thousands, except per share data)
|
Three Months Ended
June 30, |
Six Months Ended
June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Cost of revenues
|
|
|
|
|
||||||||||||
|
Gross profit (loss)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development
|
|
|
|
|
||||||||||||
|
Sales and marketing
|
|
|
|
|
||||||||||||
|
General and administrative
|
|
|
|
|
||||||||||||
|
Other operating expense, net
|
|
|
|
|
||||||||||||
|
Total operating expenses
|
|
|
|
|
||||||||||||
|
Operating loss
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Financial income (expense), net
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||
|
Other income
|
|
|
|
|
||||||||||||
|
Loss before income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Tax benefits (income taxes)
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Net loss from equity method investments
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Net basic and diluted loss per share of common stock
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Weighted average number of shares used in computing net basic and diluted loss per share of common stock
|
|
|
|
|
||||||||||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 3
SOLAREDGE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)
(in thousands, except per share data)
|
Three Months Ended
June 30, |
Six Months Ended
June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Other comprehensive income (loss), net of tax:
|
||||||||||||||||
|
Available-for-sale marketable securities
|
|
|
|
|
||||||||||||
|
Cash flow hedges
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment nature
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Foreign currency translation adjustments
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Total other comprehensive income (loss), net of tax:
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Comprehensive loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 4
SOLAREDGE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)
(in thousands, except per share data)
|
Common stock
|
||||||||||||||||||||||||||||
|
Number
|
Amount
|
Additional paid in
Capital
|
Treasury stock
|
Accumulated
other comprehensive
loss
|
Accumulated deficit
|
Total
|
||||||||||||||||||||||
|
Balance as of January 1, 2025
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
|
|||||||||||||||||||||
|
Stock based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Other comprehensive gain adjustments
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of March 31, 2025
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
|
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
*
|
|
|
|
*
|
|||||||||||||||||||||
|
Issuance of common stock under employee stock purchase plan (
|
|
*
|
(
|
)
|
|
|
|
|
||||||||||||||||||||
|
Stock based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Other comprehensive gain adjustments
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of June 30, 2025
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 5
SOLAREDGE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)
(in thousands, except per share data)
|
Common stock
|
Additional
paid in
Capital
|
Treasury stock
|
Accumulated
other comprehensive
loss
|
Retained earnings
|
Total
|
|||||||||||||||||||||||
|
Number
|
Amount
|
|||||||||||||||||||||||||||
|
Balance as of January 1, 2024
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||||||
|
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
|
|||||||||||||||||||||
|
Stock based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Repurchase of common stock
|
(
|
)
|
*
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||||
|
Other comprehensive loss adjustments
|
-
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of March 31, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||||
|
Issuance of common stock upon exercise of stock-based awards
|
|
*
|
|
|
|
|
|
|||||||||||||||||||||
|
Issuance of common stock under employee stock purchase plan
|
|
*
|
|
|
|
|
|
|||||||||||||||||||||
|
Stock based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Repurchase of common stock
|
(
|
)
|
*
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||||
|
Capped call transactions related to notes 2029
|
-
|
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||||||
|
Other comprehensive loss adjustments
|
-
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||
|
Net loss
|
-
|
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||||||||
|
Balance as of June 30, 2024
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||||
* Represents an amount less than $1.
The accompanying notes are an integral part of the condensed consolidated financial statements.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 6
SOLAREDGE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in thousands, except per share data)
|
Six Months Ended
June 30,
|
||||||||
|
2025
|
2024
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation and amortization
|
|
|
||||||
|
Impairment of asset held-for-sale
|
|
|
||||||
|
Stock-based compensation expenses
|
|
|
||||||
|
Loss from business disposition
|
|
|
||||||
|
Deferred income taxes, net
|
(
|
)
|
(
|
)
|
||||
|
Gain from repurchasing of convertible notes
|
|
(
|
)
|
|||||
|
Loss from exchange rate fluctuations
|
|
|
||||||
|
Other items
|
(
|
)
|
|
|||||
|
Changes in assets and liabilities:
|
||||||||
|
Trade receivables, net
|
(
|
)
|
|
|||||
|
Inventories, net
|
|
(
|
)
|
|||||
|
Prepaid expenses and other assets
|
|
|
||||||
|
Operating lease right-of-use assets, net
|
|
|
||||||
|
Trade payables
|
|
(
|
)
|
|||||
|
Warranty obligations
|
(
|
)
|
(
|
)
|
||||
|
Deferred revenues and customers advances
|
(
|
)
|
(
|
)
|
||||
|
Operating lease liabilities
|
(
|
)
|
(
|
)
|
||||
|
Accrued expenses and other liabilities
|
|
(
|
)
|
|||||
|
Net cash provided by (used in) operating activities
|
|
(
|
)
|
|||||
|
Cash flows from investing activities:
|
||||||||
|
Investment in available-for-sale marketable securities
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from maturities of available-for-sale marketable securities
|
|
|
||||||
|
Proceeds from sales of available-for-sale marketable securities
|
|
|
||||||
|
Purchase of property, plant and equipment
|
(
|
)
|
(
|
)
|
||||
|
Business combinations, net of cash acquired
|
|
(
|
)
|
|||||
|
Proceeds from sale of investment in privately-held company
|
|
|
||||||
|
Business dispositions, net of cash sold
|
(
|
)
|
|
|||||
|
Proceeds from sale of property, plant and equipment
|
|
|
||||||
|
Repayment related to governmental grant
|
(
|
)
|
|
|||||
|
Purchase of intangible assets
|
|
(
|
)
|
|||||
|
Disbursements for loans receivables
|
|
(
|
)
|
|||||
|
Investment in privately-held companies
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from loan receivables
|
|
|
||||||
|
Other investing activities
|
(
|
)
|
(
|
)
|
||||
|
Net cash provided by investing activities
|
$
|
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 7
SOLAREDGE TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in thousands, except per share data)
|
Six Months Ended
June 30, |
||||||||
|
2025
|
2024
|
|||||||
|
Cash flows from financing activities:
|
||||||||
|
Repurchase of common stock
|
$
|
|
$
|
(
|
)
|
|||
|
Proceeds from issuance of Notes 2029, net of issuance costs
|
|
|
||||||
|
Capped call transactions related to Notes 2029
|
|
(
|
)
|
|||||
|
Repurchase of convertible debt
|
(
|
)
|
(
|
)
|
||||
|
Other financing activities
|
(
|
)
|
(
|
)
|
||||
|
Net cash used in financing activities
|
(
|
)
|
(
|
)
|
||||
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
|
(
|
)
|
|||||
|
Increase (decrease) in cash, cash equivalents and restricted cash
|
|
(
|
)
|
|||||
|
Cash, cash equivalents and restricted cash, beginning of period
|
|
|
||||||
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
|
$
|
|
||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
The following table reconciles cash, cash equivalents and restricted cash per the statement of cash flows to the balance sheet:
|
Six Months Ended
June 30, |
||||||||
|
2025
|
2024
|
|||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Restricted cash
|
|
|
||||||
|
Cash, cash equivalents and restricted cash, end of period
|
$
|
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 8
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 1: GENERAL
| a. |
SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell intelligent inverter solutions designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features. The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughout each and every module through constant tracking of maximum power points individually per module, (ii) inverters which invert direct current (“DC”) from the PV modules to alternating current (“AC”), including the Company’s future ready Energy Hub inverter which supports, among other things, connection to a DC-coupled battery for full or partial home backup capabilities, and optional connection to the Company's smart EV charger, (iii) a remote cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters to enable customers and system owners to monitor and manage the solar PV system, (iv) batteries for PV applications that are used to increase energy independence and maximize self-consumption for PV system's owners including a battery and (v) additional smart energy management solutions.
|
The Company and its subsidiaries sell products worldwide through large distributors, electrical equipment wholesalers, directly to large solar installers and engineering, procurement, and construction firms. The Company has expanded its activity to other areas of smart energy technology organically and through acquisitions.
| b. |
Basis of Presentation:
|
The unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). In management’s opinion, the unaudited condensed consolidated financial statements reflect all adjustments of a normal recurring nature that are necessary for a fair presentation of the results for the interim periods presented. The Company’s interim period results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year.
The significant accounting policies applied in the annual consolidated financial statements of the Company as of December 31, 2024, contained in the Company’s Annual Report on Form 10-K filed with the SEC on February 25, 2025, have been applied consistently in these unaudited interim condensed consolidated financial statements. Certain prior year amounts have been reclassified to conform to current year presentation.
| c. |
Trade receivables:
|
Trade receivables are stated net of credit losses allowance. The Company is exposed to credit losses primarily through sales of products. The allowance against gross trade receivables reflects the current expected credit loss inherent in the receivables portfolio determined based on the Company’s methodology. The Company’s methodology is based on historical collection experience, customer creditworthiness, current and future economic condition and market condition. Additionally, specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default. Trade receivables are written off after all reasonable means to collect the full amount have been exhausted.
The following table provides a roll-forward of the allowance for credit losses that is deducted from the amortized cost basis of trade receivables to present the net amount expected to be collected:
|
Balance as of January 1, 2025
|
$
|
|
||
|
Increase in provision for expected credit losses
|
|
|||
|
Recoveries collected
|
(
|
)
|
||
|
Amounts written off charged against the allowance
|
(
|
)
|
||
|
Foreign currency translation
|
|
|||
|
Balance as of June 30, 2025
|
$
|
|
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 9
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
| d. |
Use of estimates:
|
The preparation of financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses, government grants, income taxes and related disclosures in the accompanying notes. Actual results and outcomes may differ from management’s estimates and assumptions due to risks and uncertainties.
| e. |
Concentrations of supply risks:
|
The Company depends on two contract manufacturers and several limited or single source component suppliers. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields, and costs.
As of June 30, 2025 two contract manufacturers jointly accounted for 38.3 % of the Company’s total trade payables.
As of December 31, 2024, two contract manufacturers jointly accounted for 43.4 % of the Company’s total trade payables.
The Company's own manufacturing facility, Sella 1, located in the North of Israel, is used in the Company' ongoing operations.
| f. |
New accounting standards updates:
|
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”). ASU 2023-09 requires additional categories of information about federal, state and foreign income taxes to be included in effective tax rate reconciliation disclosure. Additionally, the newly added categories also apply to the income taxes paid disclosure. Implementation of said additions are subject to quantitative thresholds. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the impact from ASU 2023-09 on its consolidated financial statements disclosures.
In November 2024, the FASB issued ASU 2024-03, “Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): “Disaggregation of Income (loss) Statement Expenses” (“ASU 2024-03”). ASU 2024-03 requires disaggregation of certain costs and expenses included in each relevant expense caption on the Company's consolidated income (loss) statements in a separate note to the financial statements at each interim and annual reporting period, including amounts of purchases of inventory, employee compensation, depreciation, and intangible asset amortization. ASU 2024-04 is effective fiscal years beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact from ASU 2024-03 on its consolidated financial statements disclosures.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. This amendment introduces a practical expedient for the application of the current expected credit loss (“CECL”) model to current accounts receivable and contract assets. ASU 2025-05 is effective for fiscal years beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Company is currently evaluating the timing of adoption and impact of this amendment on its Consolidated Financial Statements and related disclosures.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 10
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 2: MARKETABLE SECURITIES
The following is a summary of available-for-sale marketable securities as of June 30, 2025:
|
Amortized cost
|
Gross unrealized gains
|
Gross unrealized losses
|
Fair value
|
|||||||||||||
|
Matures within one year:
|
||||||||||||||||
|
Corporate bonds
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
U.S. Treasury securities
|
|
|
(
|
)
|
|
|||||||||||
|
U.S. Government agency securities
|
|
|
|
|
||||||||||||
|
Non-U.S. Government securities
|
|
|
(
|
)
|
|
|||||||||||
|
|
|
(
|
)
|
|
||||||||||||
|
Matures after one year:
|
||||||||||||||||
|
Corporate bonds
|
|
|
|
|
||||||||||||
|
U.S. Government agency securities
|
|
|
|
|
||||||||||||
|
|
|
|
|
|||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
The following is a summary of available-for-sale marketable securities as of December 31, 2024:
|
Amortized cost
|
Gross unrealized gains
|
Gross unrealized losses
|
Fair value
|
|||||||||||||
|
Matures within one year:
|
||||||||||||||||
|
Corporate bonds
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
U.S. Treasury securities
|
|
|
(
|
)
|
|
|||||||||||
|
U.S. Government agency securities
|
|
|
|
|
||||||||||||
|
|
|
(
|
)
|
|
||||||||||||
|
Matures after one year:
|
||||||||||||||||
|
Corporate bonds
|
|
|
(
|
)
|
|
|||||||||||
|
U.S. Government agency securities
|
|
|
|
|
||||||||||||
|
|
|
(
|
)
|
|
||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
The Company did not sell any available-for-sale marketable securities during the three and six months ended June 30, 2025.
Proceeds from sales of available-for-sale marketable securities during the three and six months ended June 30, 2024 were $51,918 1,970
As of June 30, 2025, and December 31, 2024, the Company did not record an allowance for credit losses for its available-for-sale marketable securities.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 11
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 3: INVENTORIES, NET
|
June 30,
2025
|
December 31,
2024
|
|||||||
|
Raw materials
|
$
|
|
$
|
|
||||
|
Work in process
|
|
|
||||||
|
Finished goods
|
|
|
||||||
|
Total inventories, net
|
$
|
|
$
|
|
||||
NOTE 4: PREPAID EXPENSES AND OTHER CURRENT ASSETS
|
June 30,
2025
|
December 31,
2024
|
|||||||
|
Vendor non-trade receivables1
|
$
|
|
$
|
|
||||
|
Government authorities2
|
|
|
||||||
|
Loan receivables, net
|
|
|
||||||
|
Prepayments
|
|
|
||||||
|
Asset held for sale
|
|
|
||||||
|
Other
|
|
|
||||||
|
Total prepaid expenses and other current assets
|
$
|
|
$
|
|
||||
1 Vendor non-trade receivables derived from the sale of components to manufacturing vendors who manufacture products, components and other testing equipment for the Company. The Company purchases these components directly from other suppliers. The Company does not reflect the sale of these components to the contract manufacturers in its revenues.
2 Including (1) Advanced Manufacturing Production Tax Credits (“AMPTC”), which incentivize the production of eligible components within the U.S. under IRC Section 45X, (2) income tax receivables and (3) value-added tax receivables from tax authorities.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 12
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 5: OTHER LONG TERM ASSETS
|
June 30,
2025
|
December 31,
2024
|
|||||||
|
Cloud computing arrangements
|
$
|
|
$
|
|
||||
|
Investments in privately held companies
|
|
|
||||||
|
Severance pay fund
|
|
|
||||||
|
Prepaid expenses and other
|
|
|
||||||
|
Total other long term assets
|
$
|
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 13
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 6: DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
During the six months ended June 30, 2025, the Company instituted a foreign currency cash flow hedging program to reduce the risk of a forecasted increase in the value of foreign currency cash flows, resulting from payment of salaries in Israeli currency, the New Israeli Shekels (“NIS”). The Company hedges portions of the anticipated payroll denominated in NIS for a period of one to nine months with hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges.
As of June 30, 2025, the Company entered into forward contracts and put and call options to sell U.S. dollars (“USD”) in the amounts of NIS 64 million and NIS 118 million, respectively.
In addition to the above-mentioned cash flow hedge transactions, the Company occasionally enters into derivative instrument arrangements to hedge the Company’s exposure to currencies other than USD. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of loss, under “Financial income (expense), net”.
As of June 30, 2025, the Company entered into forward contracts and put and call options to sell Euro (“EUR”) in the amounts of USD 60 million and USD 20 million, respectively.
The Company classifies cash flows related to its hedging as operating activities in its condensed consolidated statement of cash flows.
The fair values of outstanding derivative instruments were as follows:
|
Balance sheet location
|
June 30,
2025
|
December 31,
2024
|
||||||||
|
Derivative assets of options and forward contracts:
|
||||||||||
|
Designated cash flow hedges
|
Prepaid expenses and other current assets
|
$
|
|
$
|
|
|||||
|
Derivative liabilities of options and forward contracts:
|
||||||||||
|
Non-designated hedges
|
Accrued expenses and other current liabilities
|
(
|
)
|
|
||||||
Gains (losses) on derivative instruments are summarized below:
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|||||||||||||||||
|
Affected line item
|
2025
|
2024
|
2025
|
2024
|
||||||||||||||
|
Foreign exchange contracts
|
||||||||||||||||||
|
Non Designated Hedging Instruments
|
Condensed Consolidated Statements of Loss - Financial income (expense), net
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
Designated Hedging Instruments
|
Condensed Consolidated Statements of Comprehensive Loss - Cash flow hedges
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
|||||||
See Note 15 for information regarding gains (losses) from designated hedging instruments reclassified from accumulated other comprehensive loss.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 14
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 7: FAIR VALUE MEASUREMENTS
In accordance with ASC 820, “Fair Value Measurement”, the Company measures its cash equivalents and marketable securities, at fair value using the market approach valuation technique. Cash and cash equivalents are classified within Level 1 because these assets are valued using quoted market prices. Marketable securities and foreign currency derivative contracts are classified within level 2 due to these assets being valued by alternative pricing sources and models utilizing market observable inputs.
The following table sets forth the Company’s assets that were measured at fair value as of June 30, 2025, and December 31, 2024, by level within the fair value hierarchy:
|
Fair value measurements as of
|
||||||||||
|
Description
|
Fair Value
Hierarchy
|
June 30,
2025
|
December 31,
2024
|
|||||||
|
Assets:
|
||||||||||
|
Cash and cash equivalents:
|
||||||||||
|
Cash
|
Level 1
|
$
|
|
$
|
|
|||||
|
Money market mutual funds
|
Level 1
|
$
|
|
$
|
|
|||||
|
Deposits
|
Level 1
|
$
|
|
$
|
|
|||||
|
Restricted cash
|
Level 1
|
$
|
|
$
|
|
|||||
|
Derivative instruments
|
Level 2
|
$
|
|
$
|
|
|||||
|
Short-term marketable securities:
|
||||||||||
|
Corporate bonds
|
Level 2
|
$
|
|
$
|
|
|||||
|
U.S. Treasury securities
|
Level 2
|
$
|
|
$
|
|
|||||
|
U.S. Government agency securities
|
Level 2
|
$
|
|
$
|
|
|||||
|
Non-U.S. Government securities
|
Level 2
|
$
|
|
$
|
|
|||||
|
Long-term marketable securities:
|
||||||||||
|
Corporate bonds
|
Level 2
|
$
|
|
$
|
|
|||||
|
U.S. Government agency securities
|
Level 2
|
$
|
|
$
|
|
|||||
|
Liabilities:
|
||||||||||
|
Derivative instruments
|
Level 2
|
$
|
(
|
)
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 15
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 8: WARRANTY OBLIGATIONS
Changes in the Company’s product warranty obligations for the three and six months ended June 30, 2025 and 2024, were as follows:
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Balance, at the beginning of the period
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Accruals for warranty during the period
|
|
|
|
|
||||||||||||
|
Changes in estimates
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Settlements
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Balance, at end of the period
|
|
|
|
|
||||||||||||
|
Less current portion
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Long term portion
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 16
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 9: DEFERRED REVENUES AND CUSTOMERS ADVANCES
Deferred revenues consist of deferred cloud-based monitoring services, communication services, warranty extension services and advance payments received from customers for the Company’s products. Deferred revenues are classified as short-term and long-term deferred revenues based on the period in which revenues are expected to be recognized.
Changes in the balances of deferred revenues and customer advances during the period are as follows:
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Balance, at the beginning of the period
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Revenue recognized
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Increase in deferred revenues and customer advances
|
|
|
|
|
||||||||||||
|
Balance, at the end of the period
|
|
|
|
|
||||||||||||
|
Less current portion
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Long term portion
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
The following table includes estimated revenues that the Company expects to be recognized in the future, related to performance obligations that are unsatisfied (or partially unsatisfied) as of June 30, 2025:
|
2025
|
$
|
|
||
|
2026
|
|
|||
|
2027
|
|
|||
|
2028
|
|
|||
|
2029
|
|
|||
|
Thereafter
|
|
|||
|
Total deferred revenues
|
$
|
|
NOTE 10: ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
|
June 30,
2025
|
December 31,
2024
|
|||||||
|
Accrued expenses
|
$
|
|
$
|
|
||||
|
Government authorities
|
|
|
||||||
|
Operating lease liabilities
|
|
|
||||||
|
Accrual for sales incentives
|
|
|
||||||
|
Other
|
|
|
||||||
|
Total accrued expenses and other current liabilities
|
$
|
|
$
|
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 17
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 11: CONVERTIBLE SENIOR NOTES
Upon conversion, the Company may choose to pay or deliver, as the case may be, cash, shares of common stock, or a combination of cash and shares of common stock.
In addition, upon the occurrence of a fundamental change (as defined in the Indenture), holders of the Notes 2025 may require the Company to repurchase all or a portion of their Notes 2025, in multiples of $1,000 principal amounts, at a repurchase price of 100% of the principal amount of the Notes 2025, plus any accrued and unpaid special interest to, but excluding the fundamental change repurchase date. If certain fundamental changes referred to as make-whole fundamental changes occur, the conversion rate for the Notes 2025 may be increased.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 18
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
Upon conversion, the Company may choose to pay or deliver, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock.
In addition, upon the occurrence of a fundamental change (as defined in the Indenture 2029), holders of the Notes 2029 may require the Company to repurchase all or a portion of their Notes 2029, in multiples of $1,000 principal amounts, at a repurchase price of 100% of the principal amount of the Notes 2029, plus any accrued and unpaid interest, if any, up to, but not including, the repurchase date. If certain fundamental changes referred to as make-whole fundamental changes occur, the conversion rate for the Notes 2029 may be increased.
The net proceeds from the offering of the Notes 2029 were approximately $293,200 , after deducting fees and estimated expenses. Congruently, the Company has entered into capped call transactions (as detailed below). The Company used approximately $25,230 of the net proceeds from this offering to pay the cost of the capped call transactions. The Company also used approximately $267,900 of the net proceeds from this offering to repurchase $285,000 principal amount of its Notes 2025. In June 2024, the Company recorded under other income a gain of $15,456 from the repurchase of Notes 2025.
The Company accounts for the Notes 2029 at amortized cost, as a single unit of account on the balance sheet. The carrying value of the liability is represented by the face amount of the Notes 2029, less debt issuance costs, adjusted for any amortization of issuance costs. Issuance costs are being amortized as interest expense over the term of the Notes 2029, using the effective interest rate method.
The capped call transactions are expected generally to reduce the potential dilution to the common stock upon any conversion of the Notes 2029 and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Notes 2029, as the case may be, in the event that the market price per share of common stock, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions. The strike price initially corresponds to the conversion price of the Notes and is subject to customary anti-dilution adjustments. If, however, the market price per share of common stock exceeds $48.84 , the initial cap price of the capped call transactions, there would nevertheless be unmitigated dilution and/or no offset of any cash payments, in each case, attributable to the amount by which the market price of the common stock exceeds the cap price. The cap price is subject to certain customary adjustments under the terms of the capped call transactions.
The capped call transactions are considered a freestanding instrument as they were entered into separately and apart from Notes 2029. In addition, the conversion or redemption of the Notes 2029 would not automatically result in the exercise of the capped call.
As the capped call transactions are indexed to the Company's common stock, they were recorded as a reduction of additional paid-in capital in the condensed consolidated balance sheets.
On July 8, 2024 the Company sold to Goldman Sachs & Co. LLC, as representative of the several initial purchasers (the “Initial Purchasers”), and the Initial Purchasers purchased from the Company, $37,000 aggregate principal amount of additional Notes 2029. The additional Notes 2029 were sold pursuant to the Initial Purchasers’ exercise of the option granted by the Company to the Initial Purchasers to purchase additional Notes 2029, solely to cover over-allotments, under the purchase agreement described in the Company's Form 8-K filed on June 28, 2024.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 19
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
The net proceeds from the exercise of the option granted by the Company to the Initial Purchasers of the Notes 2029 were approximately $36,237 , after deducting fees and estimated expenses. Congruently, the Company has entered into additional capped call transactions. The Company used approximately $3,111 of the net proceeds from this offering to pay the cost of the additional capped call transactions. The Company intends to use the remainder of the net proceeds from the offering for general corporate purposes.
In March 2025 the Company repurchased $5,250 principal amount of its Notes 2025. The Company recorded a net gain of $146 , under other income, net, from the repurchase.
The convertible senior notes consisted of the following as of June 30, 2025 and December 31, 2024:
|
June 30,
2025
|
December 31,
2024
|
|||||||
|
Notes 2025
|
||||||||
|
Principal
|
$
|
|
$
|
|
||||
|
Unamortized issuance costs
|
(
|
)
|
(
|
)
|
||||
|
Net carrying amount Notes 2025
|
|
|
||||||
|
Notes 2029
|
||||||||
|
Principal
|
|
|
||||||
|
Unamortized issuance costs
|
(
|
)
|
(
|
)
|
||||
|
Net carrying amount Notes 2029
|
|
|
||||||
|
Total notes carrying amount
|
$
|
|
$
|
|
||||
Costs related to the Notes 2025 and the Notes 2029 for the three and six months ended June 30, 2025 and June 30, 2024 were as follows:
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Notes 2025
|
||||||||||||||||
|
Debt issuance cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Notes 2029
|
||||||||||||||||
|
Debt issuance cost
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Contractual interest expense
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
As of June 30, 2025, the unamortized issuance costs of the Notes 2025 and Notes 2029 will be amortized over the remaining term of approximately 2.4 months and 4 years, respectively.
The annual effective interest rates of the Notes 2025 and the Notes 2029 are 0.47 %. and 2.75 %, respectively.
As of June 30, 2025, the estimated fair values of Notes 2025 and Notes 2029, both of which the Company has classified as Level 2 financial instruments, are $331,983 and $255,473 , respectively. The estimated fair values were determined based on the quoted bid price of the Notes in an over-the-counter market on the last trading day of the reporting period.
As of June 30, 2025, the if-converted value of the Notes 2025 and Notes 2029 did not exceed the principal amount.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 20
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 12: OTHER LONG TERM LIABILITIES
|
June 30,
2025
|
December 31,
2024
|
|||||||
|
Tax liabilities
|
$
|
|
$
|
|
||||
|
Long term accrued expenses
|
|
|
||||||
|
Accrued severance pay
|
|
|
||||||
|
Other
|
|
|
||||||
|
$
|
|
$
|
|
|||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 21
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 13: STOCK CAPITAL
|
a.
|
Common stock rights:
|
Common stock confers upon its holders the right to receive notice of, and to participate in, all general meetings of the Company, where each share of common stock shall have one vote for all purposes, to share equally, on a per share basis, in bonuses, profits, or distributions out of fund legally available therefor, and to participate in the distribution of the surplus assets of the Company in the event of liquidation of the Company.
|
b.
|
Equity Incentive Plans:
|
The Company’s Amended and Restated 2015 Global Incentive Plan (the “2015 Plan”) became effective upon the consummation of the IPO. The 2015 Plan provides for the grant of options, restricted stock units (“RSU”), performance stock units (“PSU”), and other stock-based awards to directors, employees, officers, and non-employees of the Company and its subsidiaries. As of June 30, 2025, a total of 26,648,950 shares of common stock were reserved for issuance pursuant to stock awards under the 2015 Plan (the “Share Reserve”), an aggregate of 12,054,092 shares are still available for future grants.
Under its 2015 Plan, the Company granted PSU awards to certain employees and officers which vest upon the achievement of certain performance or market conditions subject to their continued employment with the Company.
The market condition for the PSUs is based on either the Company’s share price target or total shareholder return (“TSR”) compared to the TSR of companies listed in the S&P 500 index over a two to three year performance period or the 30-day successive average trading price of the Company’s common stock, and are subject to a three-year vesting period. The Company uses a Monte-Carlo simulation to determine the grant date fair value for these awards, which takes into consideration the market price of a share of the Company’s common stock on the date of grant less the present value of dividends expected during the requisite service period, as well as the possible outcomes pertaining to the TSR market condition. The Company recognizes such compensation expenses on an accelerated vesting method.
The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is 10,000,000 . As of June 30, 2025, an aggregate of 8,628,224 options are still available for future grants under the 2015 Plan.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 22
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
A summary of the activity in stock options and related information is as follows:
|
Number of options
|
Weighted average
exercise price
|
Weighted average
remaining contractual
term in years
|
Aggregate intrinsic
Value
|
|||||||||||||
|
Outstanding as of December 31, 2024
|
|
$
|
|
|
$
|
|
||||||||||
|
Exercised
|
(
|
)
|
|
-
|
|
|||||||||||
|
Forfeited or expired
|
(
|
)
|
|
-
|
-
|
|||||||||||
|
Outstanding as of June 30, 2025
|
|
$
|
|
|
$
|
|
||||||||||
|
Vested and expected to vest as of June 30, 2025
|
|
$
|
|
|
$
|
|
||||||||||
|
Exercisable as of June 30, 2025
|
|
$
|
|
|
$
|
|
||||||||||
The intrinsic value is the amount by which the closing price of the Company’s common stock on June 30, 2025, or the price on the day of exercise exceeds the exercise price of the stock options, multiplied by the number of in-the-money options.
A summary of the activity in the RSUs and PSUs and related information is as follows
|
RSU
|
PSU
|
|||||||||||||||
|
Number of
Shares
Outstanding
|
Weighted average
grant date fair value
|
Number of
Shares
Outstanding
|
Weighted average
grant date fair value
|
|||||||||||||
|
Unvested as of December 31, 2024
|
|
$
|
|
|
$
|
|
||||||||||
|
Granted
|
|
|
|
|
||||||||||||
|
Vested
|
(
|
)
|
|
|
|
|||||||||||
|
Forfeited
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Unvested as of June 30, 2025
|
|
$
|
|
|
$
|
|
||||||||||
|
c.
|
Employee Stock Purchase Plan (“ESPP”):
|
The Company adopted an ESPP effective upon the consummation of the IPO. As of June 30, 2025, a total of
The ESPP is implemented through an offering every six months. According to the ESPP, eligible employees may use the lesser of either up to
As of June 30, 2025, 2,311,170 shares of common stock have been purchased under the ESPP.
As of June 30, 2025, 2,814,496 shares of common stock were available for future issuance under the ESPP.
In accordance with ASC No. 718, the ESPP is compensatory and, as such, results in recognition of compensation cost.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 23
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
|
d.
|
Stock-based compensation expenses:
|
The Company recognized stock-based compensation expenses related to all stock-based awards in the consolidated statement of loss for the three and six months ended June 30, 2025, and 2024, as follows:
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Stock-based compensation expenses:
|
||||||||||||||||
|
Cost of revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Research and development
|
|
|
|
|
||||||||||||
|
Sales and marketing
|
|
|
|
|
||||||||||||
|
General and administrative
|
|
|
|
|
||||||||||||
|
Total stock-based compensation expenses
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Stock-based compensation capitalized:
|
||||||||||||||||
|
Inventory
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Other long-term assets
|
|
|
|
|
||||||||||||
|
Total stock-based compensation capitalized
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
For the three and six months ended June 30, 2025 no amounts of tax benefits were recorded in regard to stock-based compensation.
The total tax benefit associated with stock-based compensation for the three months ended June 30, 2024 was $4,744 . The tax benefit realized from stock-based compensation for the three months ended June 30, 2024 was $1,283 .
The total tax benefit associated with stock-based compensation for the six months ended June 30, 2024 was $10,110 . The tax benefit realized from stock-based compensation for the six months ended June 30, 2024 was and $2,624 .
As of June 30, 2025, there were total unrecognized compensation expenses in the amount of $170,810 related to non-vested equity-based compensation arrangements granted. These expenses are expected to be recognized during the period from July 1, 2025, through September 30, 2029.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 24
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 14: COMMITMENTS AND CONTINGENT LIABILITIES
|
a.
|
Guarantees:
|
As of June 30, 2025, contingent liabilities exist regarding guarantees in the amounts of $21,320 , $6,323 and $1,560 , for each of securing projects with customers, office rent lease agreements, and other transactions, respectively.
|
b.
|
Contractual purchase obligations:
|
The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories and other purchase orders, which cannot be canceled without penalty. In addition, the Company acquires raw materials or other goods and services, including product components, by issuing authorizations to its suppliers to purchase materials based on its projected demand and manufacturing needs.
As of June 30, 2025, the Company had non-cancellable purchase obligations totaling approximately $
As of June 30, 2025, the Company had contractual obligations for capital expenditures totaling approximately $18,489 . These commitments reflect purchases of automated assembly lines and other machinery related to the Company’s general manufacturing process and are primarily for its new manufacturing sites in the U.S.
|
c.
|
Legal claims:
|
From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular matter.
As of June 30, 2025, the Company recorded an accrual of $9,257 for legal claims which was recorded under accrued expenses and other current liabilities.
On November 3, 2023, Daphne Shen, a purported stockholder of the Company, filed a proposed class action complaint for violation of federal securities laws, individually and putatively on behalf of all others similarly situated, in the U.S. District Court of the Southern District of New York against the Company, the Company’s former CEO and the Company’s former CFO. The complaint alleges violations of Section 10(b) and Rule 10b-5 of the Exchange Act, as well as violations of Section 20(a) of the Exchange Act against the individual defendants. The complaint seeks class certification, damages, interest, attorneys’ fees, and other relief. On December 13, 2023, Javier Cascallar filed a similar proposed class action. On January 2, 2024, six purported lead plaintiffs filed motions in the Shen litigation seeking to consolidate the Cascallar and Shen litigations and appoint lead plaintiffs and lead counsel pursuant to the procedures of the Private Securities Litigation Reform Act of 1995.
On February 7, 2024, the Court consolidated the two actions (the “Consolidated Securities Litigation”), and appointed co-lead plaintiffs (the “Plaintiffs”) and lead counsel. On April 22, 2024, the co-lead Plaintiffs filed an amended complaint adding two additional officers. The amended complaint made substantially similar allegations and claims. Defendants moved to dismiss the amended complaint on July 15, 2024. On December 4, 2024, the Court issued an order granting in part the motion, dismissing all allegations except those relating to two purported misstatements. The Court allowed the Plaintiffs to again amend their complaint, and they filed a second amended complaint (the “Second Amended Complaint”) on January 3, 2025. On February 10, 2025, Defendants moved to dismiss the Second Amended Complaint. On April 7, 2025, the Court issued an order granted in part the motion, dismissing all allegations except those related to alleged misstatements characterizing inventory levels as “low” and those relating to demand in Europe. Discovery is ongoing.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 25
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
On March 15, 2024, Abdul Hirani filed a purported derivative complaint (the “Hirani Complaint”) in the U.S. District Court for the Southern District of New York against certain current and former SolarEdge executive officers and board members, including Zvi Lando, Ronen Faier, Nadav Zafrir, Betsy Atkins, Marcel Gani, Dana Gross, Dirk Hoke, Avery More, and Tal Payne. The Hirani Complaint makes largely the same allegations as those in the Consolidated Securities Litigation, namely, that the Company failed to disclose information about SolarEdge’s inventory in Europe and cancellation rates from European distributors, which allegedly resulted in material misstatements about the Company’s business and prospects in its quarterly filings. The Hirani Complaint contends that defendants’ role in allowing those alleged misstatements to be made constitutes (i) breach of fiduciary duty, (ii) aiding and abetting breach of fiduciary duty, (iii) unjust enrichment, (iv) waste of corporate assets, and (v) securities fraud under Section 10(b) of the Exchange Act. The complaint seeks compensatory and punitive damages, interest, attorneys’ fees, and other relief.
On June 10, 2024, Jonathan Blaufarb filed a second purported derivative complaint in the U.S. District Court for the Southern District of New York against the same defendants as those named in the Hirani Complaint as well as Lior Danziger and J.B. Lowe. The Blaufarb complaint makes largely the same allegations as those in the complaint in the Consolidated Securities Litigation and seeks declaratory relief, corporate governance reforms, damages, restitution, attorneys’ fees, and other relief. It also pleads the same counts as those in the Hirani Complaint, as well as additional counts for abuse of control and gross mismanagement. The Hirani and Blaufarb actions, with the Hirani matter designated as the lead case (together, the “Consolidated Derivative Actions”). On June 20, 2025, the parties agreed that the Consolidated Derivative Actions are stayed through the close of fact discovery in the Consolidated Securities Litigation.
On August 7, 2024, Edwin Isaac filed a purported derivative complaint (the “Isaac Complaint”) in the U.S. District Court for the District of Delaware against the same defendants as those named in the Consolidated Derivative Actions. The Isaac Complaint makes largely the same allegations as those in the Consolidated Securities Litigation. It also pleads the similar counts to those in the Consolidated Securities Litigation, including (i) breach of fiduciary duty, (ii) contribution, (iii) violation of Section 14(a) of the Exchange Act and SEC Rule 14a-9, (iv) unjust enrichment, (v) waste of corporate assets, and (vi) aiding and abetting breach of fiduciary duty. The complaint seeks declaratory relief, damages, interest, unspecified equitable relief, attorneys’ fees, and other relief. The parties are conferring on service of process and a possible stay of proceedings pending resolution of the motion to dismiss in the Consolidated Securities Litigation. On June 30, 2025, the parties agreed to stay the Isaac matter through the close of fact discovery in the Consolidated Securities Litigation.
On May 22, 2025, Mike Maddox (a purported shareholder) filed a derivative complaint (the “Maddox Complaint”) in the U.S. district Court for the Southern District of New York against the same Defendants as those named in the Consolidated Derivative Actions and in the Isaac matter. The Maddox Complaint makes largely the same allegations as those in the Consolidated Securities Litigation, the Consolidated Derivative Actions, and the Isaac matter. It also pleads similar counts to those in the Consolidated Derivative Actions and the Isaac matter, including (i) breach of fiduciary duty, (ii) gross mismanagement, (iii) waste of corporate assets, (iv) unjust enrichment, and (v) violation of Section 14(a) of the Exchange Act. The parties agreed to stay the Maddox matter through the close of fact discovery in the Consolidated Securities Litigation. Due to the early stage of these proceedings, the Company cannot reasonably estimate the potential range of loss, if any, or the likelihood of a potential adverse outcome. The Company disputes the allegations of wrongdoing and intends to vigorously defend against them. The parties filed a stipulation on July 21, 2025, agreeing to stay the Maddox matter through the close of fact discovery in the Consolidated Securities Litigation.
On January 13, 2025, Stellantis Europe S.p.A. (“Stellantis”) submitted an application for injunctive relief, to the Court of Turin, Italy, claiming that SolarEdge e-Mobility was allegedly in breach of contract. The application for injunctive relief is aimed at obtaining the following interim measures: i) order the Company to resume supply of spare parts and technical assistance activities in favor of Stellantis; and ii) to order the Company to pay a penalty of 100,000 Euro for each day of delay in fulfilling the order above. At a hearing on February 25, 2025 the parties discussed the case. On May 8, 2025, the court denied Stellantis’ request for injunction and on May 23, 2025 Stellantis appealed. The Company disputes the allegations of wrongdoing and intends to vigorously defend against them.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 26
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 15: ACCUMULATED OTHER COMPREHENSIVE LOSS
The following table summarizes the changes in accumulated balances of other comprehensive loss, net of taxes:
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Unrealized gains (losses) on available-for-sale marketable securities
|
||||||||||||||||
|
Beginning balance
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||
|
Revaluation
|
|
|
|
|
||||||||||||
|
Tax on revaluation
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Other comprehensive income before reclassifications
|
|
|
|
|
||||||||||||
|
Reclassification
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Tax on reclassification
|
|
|
|
|
||||||||||||
|
Gains reclassified from accumulated other comprehensive income (loss)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Net current period other comprehensive income
|
|
|
|
|
||||||||||||
|
Ending balance
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
Unrealized gains (losses) on cash flow hedges
|
||||||||||||||||
|
Beginning balance
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Revaluation
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Tax on revaluation
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Other comprehensive losses (gains) before reclassifications
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Reclassification
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Tax on reclassification
|
|
|
|
|
||||||||||||
|
Gains reclassified from accumulated other comprehensive income (loss)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Net current period other comprehensive income (loss)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Ending balance
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Foreign currency translation adjustments on intra-entity transactions that are of a long-term investment in nature
|
||||||||||||||||
|
Beginning balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Revaluation
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Ending balance
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Unrealized gains (losses) on foreign currency translation
|
||||||||||||||||
|
Beginning balance
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
Revaluation
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Ending balance
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||||
|
Total
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 27
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
The following table summarizes the reclassification out of “Accumulated other comprehensive loss”, net of taxes:
|
Details about Accumulated Other Comprehensive Loss Components
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
Affected Line Item in the Statement of Income
|
||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
||||||||||||||
|
Unrealized gains (losses) on available-for-sale marketable securities
|
|||||||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
Financial income (expense), net
|
|||||||||
|
|
(
|
)
|
|
(
|
)
|
Tax benefits (income taxes)
|
|||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
Total, net of income taxes
|
|||||||||
|
Unrealized gains (losses) on cash flow hedges, net
|
|||||||||||||||||
|
|
|
|
|
Cost of revenues
|
|||||||||||||
|
|
|
|
|
Research and development
|
|||||||||||||
|
|
|
|
|
Sales and marketing
|
|||||||||||||
|
|
|
|
|
General and administrative
|
|||||||||||||
|
$
|
|
$
|
|
$
|
|
$
|
|
Total, before income taxes
|
|||||||||
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
Tax benefits (income taxes)
|
|||||||||
|
|
|
|
|
Total, net of income taxes
|
|||||||||||||
|
Total reclassifications for the period
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||
NOTE 16: OTHER OPERATING EXPENSE, NET
The following table presents the expenses (income) recorded in the three and six months ended June 30, 2025, and 2024:
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Impairment of asset-held for sale
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Loss from business disposition
|
|
|
|
|
||||||||||||
|
Loss (gain) from sale of property, plant and equipment
|
(
|
)
|
|
(
|
)
|
|
||||||||||
|
Income from discontinued operations
|
|
|
(
|
)
|
|
|||||||||||
|
Other
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|||||||||
|
Total other operating expense, net
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 28
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 17: RESTRUCTURING AND OTHER EXIT ACTIVITIES
On January 21, 2024, the Company announced the adoption of a restructuring plan in response to challenging industry conditions . Under this restructuring plan, the Company reduced its headcount by approximately 900 employees over the first half of 2024 in an involuntary workforce reduction. The adoption of this restructuring plan followed the Company’s previous measures taken to align with current market conditions, including termination of manufacturing in Mexico, reduction of manufacturing capacity in China, and discontinuation of the Company’s light commercial vehicle e-mobility activity. On July 15, 2024, the Company announced additional workforce reductions, resulting in the layoff of 400 employees.
On November 27, 2024, the Company announced the closure of its Energy Storage Division. In connection with the closure, the Company reduced its headcount by approximately 500 employees, primarily in manufacturing positions in South Korea. This closure and associated headcount reduction represented approximately 12% of the Company’s overall employee population, at the time, almost all of whom were dismissed over the first half of 2025 (together with the 2024 workforce reductions, the “Restructuring Plans”). The Company has determined that the discontinuation of its Energy Storage activity does not represent a strategic shift that will have a major effect on the Company's operations and financial results and therefore it did not meet the criteria for discontinued operations classification.
Restructuring and other exit charges for the three months ended June 30, 2025 and June 30, 2024, by type of cost were as follows:
|
Three Months Ended June 30, 2025
|
Three Months Ended June 30, 2024
|
|||||||||||||||||||||||
|
Employee termination
costs
|
Contract termination and
other
|
Total
|
Employee termination
costs
|
Contract termination and
other
|
Total
|
|||||||||||||||||||
|
Cost of revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Research and development
|
|
|
|
|
|
|
||||||||||||||||||
|
Sales and marketing
|
|
|
|
|
|
|
||||||||||||||||||
|
General and administrative
|
|
|
|
|
|
|
||||||||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Restructuring and other exit charges for the six months ended June 30, 2025, and June 30, 2024, by type of cost were as follows:
|
Six Months Ended June 30, 2025
|
Six Months Ended June 30, 2024
|
|||||||||||||||||||||||
|
Employee termination
costs
|
Contract termination and
other
|
Total
|
Employee termination
costs
|
Contract termination and
other
|
Total
|
|||||||||||||||||||
|
Cost of revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Research and development
|
|
|
|
|
|
|
||||||||||||||||||
|
Sales and marketing
|
|
|
|
|
|
|
||||||||||||||||||
|
General and administrative
|
|
|
|
|
|
|
||||||||||||||||||
|
Other operating expenses
|
|
(
|
)
|
(
|
)
|
|
|
|
||||||||||||||||
|
Total
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
$
|
|
|||||||||||
The Company’s liability balance for the restructuring and other exit charges is as follows:
|
Employee termination
costs
|
Contract termination and
other
|
|||||||
|
Balance as of December 31, 2024
|
$
|
|
$
|
|
||||
|
Charges
|
||||||||
|
Cash payments
|
( |
) | ( |
) | ||||
|
Non-cash utilization and other
|
( |
) | ||||||
|
Balance as of June 30, 2025
|
$ |
$ |
||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 29
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 18: INCOME TAXES
For the three months ended June 30, 2025, the Company reported income taxes at an effective tax rate of negative 4.8 % including discrete items, compared to the three months ended June 30, 2024, where the Company reported income taxes at an effective tax rate of 8.6 %.
For the six months ended June 30, 2025, the Company reported income taxes at an effective tax rate of negative 5.4 % including discrete items, compared to the six months ended June 30, 2024, where the Company reported income taxes at an effective tax rate of 11.1 %.
The negative effective tax rate in the three and six months ended June 30, 2025 resulted primarily from the valuation allowance on current losses and capital losses, coupled with an increase in the provision for uncertain tax positions. The effective tax rate in the corresponding periods in 2024 was mainly due to impairments and disposals, which significantly increased the quarterly loss before income tax, partially offset by higher tax expenses resulting from an increase in the valuation allowance during that quarter.
Deferred tax assets are evaluated for future realization and reduced by a valuation allowance to the extent that the Company believes they will not be realized. The Company considers all available evidence, including historical information, long range forecast of future taxable income and evaluation of tax planning strategies. Amounts recorded for valuation allowance can result from a complex series of judgments about future events and can rely on estimates and assumptions. Based primarily on the negative evidence outweighing the positive evidence, including the Company's three year cumulative, consolidated GAAP loss, historical tax losses and the difficulty in forecasting excess tax benefits related to equity-based compensation, the Company believes there is uncertainty as to when it will be possible to utilize certain net operating losses (each an “NOL”), credit carryforwards, capital losses and other deferred tax assets. Therefore, the Company recorded a valuation allowance against the deferred tax assets for which it is more-likely-than-not they will not be realized.
Should the Company's operating results improve and projections show continued utilization of the tax attributes, the Company would consider that as significant positive evidence and future reassessment may result in the determination that all or a portion of the valuation allowance is no longer required. If this were to occur, any reversal of the valuation allowance would result in a corresponding non-cash income tax benefit, thereby increasing total deferred tax assets.
In July 2025, the One Big Beautiful Bill Act (the “OBBB”) was enacted into law modifying clean energy tax credits contained in the Inflation Reduction Act (“IRA”) and imposing new eligibility criteria related thereto. As the OBBB was signed into law after June 30, 2025, the financial impact is not included in the Company's operating results for the three and six months ended June 30, 2025. The Company is currently assessing the impact the OBBB will have on its condensed consolidated financial statements.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 30
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 19: LOSS PER SHARE
The following table presents the computation of basic and diluted loss per share (“EPS”):
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Basic EPS:
|
||||||||||||||||
|
Numerator:
|
||||||||||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Denominator:
|
||||||||||||||||
|
Shares used in computing net loss per share of common stock, basic
|
|
|
|
|
||||||||||||
|
Diluted EPS
|
||||||||||||||||
|
Numerator:
|
||||||||||||||||
|
Net loss attributable to common stock, diluted
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
|
Denominator:
|
||||||||||||||||
|
Shares used in computing net loss per share of common stock, diluted
|
|
|
|
|
||||||||||||
|
Loss per share:
|
||||||||||||||||
|
Basic and Diluted
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
The following outstanding shares of common stock equivalents were excluded from the calculation due to their antidilutive nature:
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Stock-based awards
|
|
|
|
|
||||||||||||
|
Notes 2025
|
|
|
|
|
||||||||||||
|
Notes 20291
|
|
|
|
|
||||||||||||
|
Total shares excluded
|
|
|
|
|
||||||||||||
1 In conjunction with the issuance of the Notes 2029 in June 2024, the Company used approximately $25,230 of the net proceeds from this offering to pay the cost of the capped call transactions. In July 2024, following an additional issuance of the Notes 2029, $3,111 of net proceeds were used to pay the cost of capped call transactions. In accordance with FASB ASC 260, antidilutive contracts, such as purchased call options are excluded from the computation of diluted net income (loss) per share. Accordingly, any potential impact resulting from capped call transaction is excluded from the Company's computation of diluted net income (loss) per share.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 31
SOLAREDGE TECHNOLOGIES INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(in thousands, except per share data)
NOTE 20: SEGMENT INFORMATION
Following the sale of Automation Machines and the discontinuation of the Company's Energy Storage activity in 2024, the Company now operates as one operating segment that constitutes consolidated results. The Company recast its comparative numbers to conform to current period presentation.
The Company's Chief Executive Officer, who is the chief operating decision maker (“CODM”), makes resource allocation decisions and assesses performance based on financial information presented on a consolidated net loss, accompanied by disaggregated information about significant expenses.
The Company’s CODM does not regularly review asset information and, therefore, the Company does not report asset information.
The segment includes the design, development, manufacturing, and sales of an intelligent inverter solution designed to maximize power generation at the individual PV module level and batteries for PV applications. The segment solution consists mainly of the Company’s power optimizers, inverters, batteries and cloud‑based monitoring platform.
The following tables present information on reportable loss for the period presented:
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Less:
|
||||||||||||||||
|
Direct costs of goods
|
|
|
|
|
||||||||||||
|
Salaries1
|
|
|
|
|
||||||||||||
|
Inventory costs
|
(
|
)
|
(
|
)
|
|
|
|
|||||||||
|
Shipment and logistics
|
|
|
|
|
||||||||||||
|
Warranty
|
|
|
|
|
||||||||||||
|
Depreciation and amortization
|
|
|
|
|
||||||||||||
|
Directly related overhead costs
|
|
|
|
|
||||||||||||
|
Other2
|
|
|
|
|
||||||||||||
|
Financial (income) expense, net
|
|
|
(
|
)
|
|
|||||||||||
|
Income taxes (tax benefit)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
|
Net loss from equity method investments
|
|
|
|
|
||||||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
1 Including stock-based compensation expenses.
2 Represents indirect costs of goods, consultants and sub-contractors, marketing, bad debt and impairments and dispositions.
The following table presents revenues disaggregated by geographical location:
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
United States
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Europe
|
|
|
|
|
||||||||||||
|
International markets
|
|
|
|
|
||||||||||||
|
Total revenues
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | F - 32
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Statements contained in this Form 10-Q or statements incorporated by reference from documents we have filed with the Securities and Exchange Commission may contain forward-looking statements that are based on our management’s expectations, estimates, projections, beliefs and assumptions in accordance with information currently available to our management. Forward-looking statements should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included in Part 1, Item 1 of this report. This discussion contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include information concerning our possible or assumed future results of operations, business strategies, technology developments, new products and services, financing and investment plans, competitive position, backlog, industry and regulatory environment, effects of acquisitions, growth opportunities, potential future impairments, and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipate,” “believe,” “could,” “seek,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” or similar expressions and the negatives of those terms.
Forward-looking statements inherently involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Given these uncertainties, you should not place undue reliance on forward-looking statements. Forward-looking and other statements regarding our sustainability efforts and aspirations are not an indication that these statements are necessarily material to investors or requiring disclosure in our filing with the Securities and Exchange Commission (“SEC”). In addition, historical, current and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve and assumptions that are subject to change in the future, including future rule-making. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this filing. Important factors that could cause actual results to differ materially from our expectations include:
| • | future demand for renewable energy including solar energy solutions; |
| • | our ability to forecast demand for our products accurately and to match production to such demand as well as our customers' ability to forecast demand based on inventory levels; |
| • | changes in tax laws, tax treaties, and regulations or the interpretation of them, including the Inflation Reduction Act and the One Big Beautiful Bill Act; |
| • | changes in the U.S. and global trade environments, including the imposition and/or increase of import tariffs or other restrictive trade measures; |
| • | ability to successfully operate our global operations with a reduced work force; |
| • | macroeconomic conditions in our domestic and international markets, such as inflation concerns, interest rates and recessionary concerns; |
| • | changes, elimination or expiration of government subsidies and economic incentives for on-grid solar energy applications; |
| • | the retail price of electricity derived from the utility grid or alternative energy sources; |
| • | interest rates and supply of capital in the global financial markets in general and in the solar market specifically; |
| • | competition, including introductions of power optimizer, inverter and solar photovoltaic (“PV”) system monitoring products by our competitors; |
| • | developments in alternative technologies or improvements in distributed solar energy generation; |
| • | historic cyclicality of the solar industry and periodic downturns; |
| • | product quality or performance problems in our products; |
| • | loss of key executives, and our ability to retain key personnel and attract additional qualified personnel |
| • | shortages, delays, price changes, or cessation of operations or production affecting our suppliers of key components; |
| • | delays, disruptions, and quality control problems in manufacturing; |
| • | our dependence upon a small number of outside contract manufacturers and limited or single source suppliers; |
| • | changes to net metering policies or the reduction, elimination or expiration of government subsidies and economic incentives for on-grid solar energy applications; |
| • | capacity constraints, delivery schedules, manufacturing yields, and costs of our contract manufacturers and availability of components; |
| • | performance of distributors and large installers in selling our products; |
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 3
| • | consolidation in the solar industry among our customers and distributors; |
| • | our ability to effectively manage changes in our organization and expansion into new markets; |
| • | our ability to recognize expected benefits from restructuring plans; |
| • | any unauthorized access to, disclosure, or theft of personal information or unauthorized access to our network or other similar cyber incidents; |
| • | our ability to implement our new Enterprise Resource Planning ("ERP") system; |
| • | our ability to integrate acquired businesses; |
| • | disruption to our business operations due to the evolving state of war in Israel and political conditions related to the war and Israeli government's plans to significantly reduce the Israeli Supreme Court's judicial oversight; |
| • | our dependence on ocean transportation to timely deliver our products in a cost-effective manner; |
| • | fluctuations in global currency exchange rates; |
| • | the impact of evolving legal and regulatory requirements, including corporate social responsibility and sustainability, requirements; |
| • | existing and future responses to and effects of pandemics, epidemics or other health crises; |
| • | federal, state, and local regulations governing the electric utility industry with respect to solar energy; |
| • | business practices and regulatory compliance of our raw material suppliers; |
| • | our ability to maintain our brand and to protect and defend our intellectual property; |
| • | volatility of our stock price; |
| • | our customers’ financial stability, creditworthiness, and debt leverage ratio; |
| • | our ability to effectively design, launch, market, and sell new generations of our products and services; |
| • | our ability to retain, and events affecting, our major customers; |
| • | natural disasters, public health events and other disruptions; |
| • | impairment of our goodwill or other long-lived and intangible assets; |
| • | our liquidity and ability to service our debt; |
the other factors set forth below in Part II, Item 1.A under “Risk Factors and in Part I, Item 1A under Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 and in other documents we file from time to time with the SEC that disclose risks and uncertainties that may affect our business.
The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 4
Overview
We develop, manufacture and sell products in a solar segment that addresses a broad range of energy market segments through our diversified product offering, including residential, commercial and large scale photovoltaic or PV, home energy management, grid services and virtual power plants. In prior years, we also had product offerings for the e-mobility market, automation machines (“Automation Machines”) and energy storage. In October 2023, we decided to discontinue our light commercial vehicle (“LCV”), e-Mobility activity. In October 2024, the Company completed the sale of Automation Machines. Additionally, in November 2024, the Company announced the closure of its Energy Storage Division, and in April 2025, we divested from our PV tracker business, as part of its effort to focus on its core activities.
Following the sale of Automation Machines and the discontinuation of the Energy Storage activity in 2024, the Company now operates as one operating segment, the Solar segment, that constitutes consolidated results.
In light of the Inflation Reduction Act (the “IRA”) legislation in the United States, which incentivizes the local manufacturing of renewable energy products by providing benefits to installers for the purchase and installation of product with domestic content, as well as by incentivizing local manufacturing of our products, we manufacture the vast majority of our products in the United States. This includes residential inverters in Texas, optimizers and commercial inverters in Florida, and ramping up manufacturing of batteries in Utah. As part of our effort to streamline and centralize, we have discontinued manufacturing in China, Mexico, and Hungary. We continue to manufacture a minor portion of our products in Israel, at our Sella 1 facility. We also continue to maintain manufacturing capabilities in Vietnam, with a third-party manufacturer. As of June 30, 2025, we shipped approximately 137.0 million power optimizers, 6.0 million inverters and 380.2 thousand batteries for PV applications. Over 4.4 million installations, many of which may include multiple inverters, are currently connected to, and monitored through, our cloud-based monitoring platform. As of June 30, 2025, we shipped approximately 58.6 GW of our DC optimized inverter systems and approximately 2.7 GWh of our batteries for PV applications.
Our revenues for the three months ended June 30, 2025, and 2024 were $289.4 million and $265.4 million, respectively. Gross profit as a percentage of revenue was 11.1% for the three months ended June 30, 2025, compared to our gross loss as a percentage of revenue of 4.1% for the three months ended June 30, 2024. Net loss for the three months ended June 30, 2025, and 2024 was $124.7 million and $130.8 million, respectively.
Our revenues for the six months ended June 30, 2025, and 2024 were $508.9 million and $469.8 million, respectively. Gross profit as a percentage of revenue was 9.8% for the six months ended June 30, 2025, compared to our gross loss as a percentage of revenue of 7.9% for the six months ended June 30, 2024. Net loss for the six months ended June 30, 2025 and 2024 was $223.3 million and $288.1 million respectively.
Global Circumstances Influencing our Business and Operations
Demand for Products
We have seen a slowdown in demand for our products in the United States and, to a greater extent, in Europe since the second part of the third quarter of 2023, and throughout 2024, and continuing in Europe into the first half of 2025. We attribute this slowdown to high inventory in the channels and slower than expected installation rates. In the United States, we are seeing an increase in demand for our products, which has coincided largely with normalized inventory levels in that region, during the first half of 2025. In Europe, inventory levels continued to be elevated in the first half of 2025 but a majority of our distribution partners have reached normalized inventory levels by the end of the second quarter 2025. The prolonged softness in demand has continued to adversely impact our results of operations.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 5
Impact of The One Big Beautiful Bill Act on U.S. Tax Incentives
On July 4, 2025, the One Big Beautiful Bill Act (the “OBBB”), was enacted into law introducing amendments to the clean energy tax credits contained in the IRA. The IRA provides energy tax credits that are significant to SolarEdge and its U.S. based customers, and material changes thereto could adversely affect our revenue, our eligibility for certain tax credits, tax credits available to our customers, competitiveness and demand for our products and our financial condition. The OBBB accelerates the phase-out timeline for certain credits and imposes new eligibility criteria.
Section 45X of the Internal Revenue Code (the “Code”) as enacted by the IRA offers Advanced Manufacturing Production Tax Credits (“AMPTC”s) that incentivize the manufacturing of eligible components within the U.S. The OBBB does not shorten the term of such Section 45X credits. The Company established manufacturing capabilities in the U.S. in 2023, and further expanded such capabilities in 2024 and 2025. On October 24, 2024, regulations concerning the application of Section 45X were published by the U.S. Treasury Department which contain detailed rules concerning eligibility, qualifying and accounting for AMPTCs. Of particular relevance to the Company are the tax credits that we generate as a result of rules concerning the qualification and measurement of AMPTCs to Residential Inverters, Commercial Inverters and DC-Optimized Inverter Systems that we manufacture in the United States. In 2024 and the first half of 2025, we sold a significant part of the AMPTCs that we generated from our U.S. production of eligible components.
Among other changes, the OBBB shortens the term of the investment tax credit and production tax credit under Section 48E and 45Y of the Code, used by customers of SolarEdge who are engaged in third-party ownership (“TPO”) models, such as residential solar leases and power purchase agreements, and commercial solar customers and developers, shortening the end date from 2034 to 2027. However, the OBBB also includes a 12-month window in which such customers can begin construction giving them four years to complete their projects. Projects begun after twelve months from enactment of the OBBB must be placed in service by December 31, 2027, to receive the credit. The OBBB eliminates the individual residential tax credit under Section 25D of the Code at the end of 2025. These changes may negatively impact the eligibility of our customers and individuals to obtain tax credits, which may negatively affect the overall demand for our products.
The OBBB also amends the domestic content bonus credit rules for Section 48E projects. Projects commencing construction after June 16, 2025 must meet a 45% domestic cost threshold, up from 40%, and the threshold thereafter increases on an annual basis until 2029. If we are unable to meet the revised domestic content requirements, our customers’ eligibility to qualify for certain tax credits could be impaired, which may adversely affect our revenue, gross margins, business operations and competitive position. In addition, the OBBB introduced new Foreign Entity of Concern (“FEOC”) requirements for Sections 45X, 45Y, and 48E of the Code. These restrictions will require threshold percentages of non FEOC material that increase over time, beginning in 2026. If we are unable to meet the revised FEOC requirements, our or our customers’ eligibility to qualify for certain tax credits could be impaired, which may adversely affect our revenue, gross margins, business operations and competitive position.
On July 7, 2025, the President issued an Executive Order titled “Ending Market Distorting Subsidies for Unreliable, Foreign Controlled Energy Sources.” This directive instructs the U.S. Department of the Treasury to issue revised guidance within 45 days. There are multiple areas of the OBBB that require the U.S. Treasury Department to provide guidance and this guidance may impact beginning of construction requirements applicable to our customers or create challenges for SolarEdge to meet the FEOC requirements. If we are unable to meet the requirements this may adversely affect our revenue, our or our customers eligibility to obtain certain tax credits, the overall demand for our products, our results of operations and cash flows.
Trade Tariff Uncertainties
The current trade situation is creating uncertainty about what impact new or existing tariffs, trade restrictions or retaliatory actions may have on us, the solar industry, our partners, and our customers. We have relocated our contract manufacturing to the United States, where we manufacture the vast bulk of our products. We continue to manufacture a minor portion of our products in Israel, at our Sella 1 facility. Certain critical subcomponents for our products are still sourced from outside the United States. If not resolved, the escalation in trade tensions or the implementation of broader tariffs, trade restrictions or other retaliatory measures on our products or components or subcomponents originating from countries outside of the United States, could adversely impact our ability to source necessary components or subcomponents, manufacture products at competitive cost, or sell our products at prices customers are willing to pay. In addition, retaliatory measures from other countries on products originating from the United States for export could adversely impact our ability to sell our products at competitive prices in such countries. Certain of the subcomponents used in our products are being imported to the United States from China, which may be subject to significantly increased tariffs. In light of the aforementioned, we are exploring alternative suppliers outside of China, however, there is no assurance that we will be successful in identifying suitable alternatives, or that such alternatives, if identified, will not result in increased costs or reduced operational efficiency.
If the price of solar power systems increases, as well as the cost of manufacturing our products in the United States, the use of solar power systems could become less economically feasible and could further reduce our gross margins or reduce the demand of solar power systems manufactured and sold, which in turn may decrease demand for our products. Additionally, existing or future tariffs may negatively affect key partners, suppliers and manufacturers. Such outcomes could adversely affect the amount or timing of our revenue, results of operations or cash flows, and continuing uncertainty could cause sales volatility, price fluctuations or supply shortages or cause our customers to advance or delay their purchase of our products. Any such developments could materially and adversely affect our business operations, results of operations and cash flows.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 6
Disruptions Due to the War in Israel
Due to the war that began on October 7, 2023, some of our employees in Israel were called to active reserve duty and additional employees may be called in the future, if needed. In the three months ended June 30, 2025, approximately 10% of our employees in Israel were called to active reserve duty for varying periods. In the second quarter of 2025, Israel and the Islamic Republic of Iran also engaged in a 12-day war, which has since stabilized due to a brokered ceasefire.
While our offices and facilities are open worldwide, including in Israel, and, to date, we have not had disruptions to our ability to manufacture and deliver products and services to customers. An escalation of the current conflicts in Israel could materially adversely affect our business, financial condition, and results of operations. Due to the ongoing and evolving nature of the conflict in Israel, and the extent of these events, the adverse effect on our business operations is still unknown.
The majority of our key employees and officers are residents of Israel. If any of our facilities in Israel were to be damaged, destroyed or otherwise rendered unable to operate, whether due to war, acts of hostility, earthquakes, fire, floods, storms, other natural disasters, employee malfeasance, terrorist acts, power outages or otherwise, or if performance of our research and development is disrupted for any other reason, such an event could delay commercialization of our products, and if we choose to manufacture all or any part of them internally, jeopardize our ability to manufacture our products as promptly as our prospective customers will likely expect, or possibly at all. If we experience delays in achieving our development objectives within a timeframe that meets our prospective customers’ expectations, our business, prospects, financial results and reputation could be harmed.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 7
Key Operating Metrics
In managing our business and assessing financial performance, we supplement the information provided in our financial statements with other operating metrics. These operating metrics are utilized by our management to evaluate our business, measure our performance, identify trends affecting our business and formulate projections. We use metrics relating to shipments of inverters, power optimizers and megawatts to evaluate our sales performance and to track market acceptance of our products.
We provide the “megawatts shipped” and “megawatt hours shipped” metrics, which are calculated based on inverter or battery nameplate capacity shipped, respectively, to show adoption of our system on a nameplate capacity basis. Nameplate capacity shipped is the maximum rated power output capacity of an inverter or battery, and corresponds to our financial results in that higher total nameplate capacities shipped are generally associated with higher total revenues. However, revenues may increase in a non-correlated manner to the “megawatt shipped” metric since other products, such as power optimizers, are not accounted for in this metric.
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Inverters shipped | 88,954 | 65,772 | 173,487 | 134,654 | ||||||||||||
Power optimizers shipped | 2,742,725 | 2,001,614 | 4,994,321 | 3,072,601 | ||||||||||||
Megawatts shipped1 | 1,194 | 873 | 2,402 | 1,819 | ||||||||||||
Megawatt hours shipped - batteries for PV applications | 247 | 128 | 427 | 256 | ||||||||||||
1 Excluding batteries for PV applications, based on the aggregate nameplate capacity of inverters shipped during the applicable period. Nameplate capacity is the maximum rated power output capacity of an inverter, as specified by the manufacturer.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 8
Results of Operations
The results of operations presented below should be reviewed in conjunction with the condensed consolidated financial statements and related notes included elsewhere in this report.
The following table sets forth selected consolidated statements of loss data for each of the periods indicated.
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
(In thousands) | ||||||||||||||||
Revenues | $ | 289,429 | $ | 265,405 | $ | 508,909 | $ | 469,804 | ||||||||
Cost of revenues | 257,298 | 276,374 | 459,242 | 506,960 | ||||||||||||
Gross profit (loss) | 32,131 | (10,969 | ) | 49,667 | (37,156 | ) | ||||||||||
Operating expenses: | ||||||||||||||||
Research and development | 53,386 | 69,276 | 115,383 | 144,627 | ||||||||||||
Sales and marketing | 28,725 | 39,978 | 60,382 | 78,889 | ||||||||||||
General and administrative | 19,789 | 39,008 | 49,972 | 69,873 | ||||||||||||
Other operating expense, net | 45,724 | 951 | 42,149 | 3,342 | ||||||||||||
Total operating expenses | 147,624 | 149,213 | 267,886 | 296,731 | ||||||||||||
Operating loss | (115,493 | ) | (160,182 | ) | (218,219 | ) | (333,887 | ) | ||||||||
Financial income (expense), net | (7,323 | ) | (865 | ) | 2,745 | (7,929 | ) | |||||||||
Other income | 4,017 | 18,551 | 4,165 | 18,551 | ||||||||||||
Loss before income taxes | (118,799 | ) | (142,496 | ) | (211,309 | ) | (323,265 | ) | ||||||||
Tax benefits (income taxes) | (5,657 | ) | 12,245 | (11,383 | ) | 35,999 | ||||||||||
Net loss from equity method investments | (288 | ) | (567 | ) | (575 | ) | (863 | ) | ||||||||
Net loss | $ | (124,744 | ) | $ | (130,818 | ) | $ | (223,267 | ) | $ | (288,129 | ) | ||||
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 9
Comparison of three and six months ended June 30, 2025, and the three and six months ended June 30, 2024
Revenues
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Revenues | $ | 289,429 | $ | 265,405 | $ | 24,024 | 9.1 | % | $ | 508,909 | $ | 469,804 | $ | 39,105 | 8.3 | % | ||||||||||||||||
Revenues increased by $24.0 million, or 9.1%, in the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to (i) an increase of $42.1 million related to an increase in the number of inverters and power optimizers sold; and (ii) an increase of $20.4 million related to an increase in the number of batteries for PV applications sold; these were partially offset by (i) a decrease of $19.9 million related to less ancillary solar products sold; and (ii) a decrease of $13.3 million in revenues due to the discontinuation of our Energy Storage Business.
Revenues from outside of the U.S. comprised 36.0% of our revenues in the three months ended June 30, 2025 compared to 63.4% in the three months ended June 30, 2024.
The number of power optimizers recognized as revenues increased by approximately 0.6 million units, or 31.9%, from approximately 2.0 million units, in the three months ended June 30, 2024, to approximately 2.6 million units in the three months ended June 30, 2025. The number of inverters recognized as revenues increased by approximately 20.8 thousand units, or 31.9%, from approximately 65.4 thousand units in the three months ended June 30, 2024 to approximately 86.2 thousand units in the three months ended June 30, 2025. The megawatt hours of batteries for PV applications recognized as revenues increased by approximately 99.4 megawatt hours, or 79.2% from approximately 125.4 in the three months ended June 30, 2024 to approximately 225.0 megawatt hours in the three months ended June 30, 2025.
Our blended Average Selling Price (“ASP”) per watt for solar products excluding batteries for PV applications is calculated by dividing the sales of solar products, excluding the sales of batteries for PV applications, by the name plate capacity of inverters shipped. Our blended ASP per watt for solar products shipped excluding batteries for PV applications decreased by $0.030, or 13.9%, in the three months ended June 30, 2025, compared to the three months ended June 30, 2024. This decrease in blended ASP per watt is primarily attributed to price reductions, mainly in Europe. This decrease in blended ASP per watt was partially offset by a higher number of power optimizers shipped, compared to the number of inverters shipped; as well as higher ASP due to increase in U.S. sales compared to sales in Europe, which have a higher ASP per watt out of our total solar product mix.
Our blended ASP per watt/hour for batteries for PV applications is calculated by dividing batteries for PV applications sales, by the nameplate capacity of batteries for PV applications shipped. Our blended ASP per watt/hour for batteries for PV applications decreased by $0.071, or 19.2%, in the three months ended June 30, 2025, compared to the three months ended June 30, 2024. The decrease in blended ASP per watt/hour is mainly attributed to a price reduction of our batteries for PV applications as well as an increase in the sale of our three-phase battery that is sold at a lower ASP per watt/hour.
Revenues increased by $39.1 million, or 8.3%, in the six months ended June 30, 2025 compared to the six months ended June 30, 2024, primarily due to (i) an increase of $74.7 million related to an increase in the number of inverters and power optimizers sold; (ii) an increase of $24.2 million related to the higher number of batteries for PV applications sold; these were partially offset by (i) a decrease of $34.0 million related to less ancillary solar products sold; and (ii) a decrease of $16.8 million in revenues due to the discontinuation of our Energy Storage Business.
Revenues from outside of the U.S. comprised 37.7% of our revenues in the six months ended June 30, 2025 compared to 65.4% in the six months ended June 30, 2024.
The number of power optimizers recognized as revenues increased by approximately 1.7 million units, or 54.9%, from approximately 3.1 million units, in the six months ended June 30, 2024, to approximately 4.8 million units in the six months ended June 30, 2025. The number of inverters recognized as revenues increased by approximately 30.5 thousand units, or 23.9%, from approximately 127.7 thousand units in the six months ended June 30, 2024 to approximately 158.1 thousand units in the six months ended June 30, 2025. The megawatt hours of batteries for PV applications recognized as revenues increased by approximately 172.0 megawatt hours, or 80.4% from approximately 214.3 megawatt hours in the six months ended June 30, 2024 to approximately 386.0 megawatt hours in the six months ended June 30, 2025.
Our blended ASP per watt for solar products shipped excluding batteries for PV applications decreased by $0.014, or 7.1%, in the six months ended June 30, 2025 compared to the six months ended June 30, 2024. This decrease in blended ASP per watt is primarily attributed to price reductions, mainly in Europe. This decrease in blended ASP per watt was partially offset by a higher number of power optimizers shipped, compared to the number of inverters shipped; as well as higher ASP due to increase in U.S. sales compared to sales in Europe, which is characterized by a higher demand for residential products, which have a higher ASP per watt out of our total solar product mix.
Our blended ASP per watt/hour for batteries for PV applications decreased by $0.089, or 23.7%, in the six months ended June 30, 2025, compared to the six months ended June 30, 2024. The decrease in blended ASP per watt/hour is mainly attributed to price reduction of our batteries for PV applications as well as an increase in the sale of our three-phase battery that is sold at a lower ASP per watt/hour.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 10
Cost of Revenues and Gross Profit (loss)
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Cost of revenues | $ | 257,298 | $ | 276,374 | $ | (19,076 | ) | (6.9 | )% | $ | 459,242 | $ | 506,960 | $ | (47,718 | ) | (9.4 | )% | ||||||||||||||
Gross profit (loss) | $ | 32,131 | $ | (10,969 | ) | $ | 43,100 | (392.9 | )% | $ | 49,667 | $ | (37,156 | ) | $ | 86,823 | (233.7 | ) % | ||||||||||||||
Cost of revenues decreased by $19.1 million, or 6.9%, in the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to:
| • | a decrease in warranty expenses and warranty accruals of $14.7 million associated primarily with a lower cost of materials; |
| • | a decrease in indirect cost of revenues of $3.5 million; and |
| • | a decrease in personnel-related costs of $3.5 million, resulting from our Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics. |
These were partially offset by an increase in direct cost of revenues sold of $5.1 million, associated primarily with the increase in revenues, which was partially offset by the AMPTC recognized.
Gross profit as a percentage of revenue was 11.1% in the three months ended June 30, 2025, compared to gross loss as a percentage of revenue of 4.1%, in the three months ended June 30, 2024, primarily due to:
| • | a decrease in warranty expenses and warranty accruals of approximately 6% associated primarily with a lower cost of materials; |
| • | lower absolute fixed and other production related costs, which were divided this quarter by significantly higher revenue, resulting in lower gross margin of approximately 6%; and |
| • | an improvement in the direct cost of revenue of approximately 4% associated primarily with the increase of US made products and the AMPTC recognized, which was offset by an increase in costs due to the manufacturing in the U.S, price reductions and a higher portion batteries for PV applications out of our total product mix. |
Cost of revenues decreased by $47.7 million, or 9.4%, in the six months ended June 30, 2025 compared to the six months ended June 30, 2024, primarily due to:
| • | a decrease in warranty expenses and warranty accruals of $31.9 million associated primarily with a lower cost of materials; |
| • | a decrease in indirect cost of revenues, associated primarily with a decrease in inventory write-downs of $6.0 million; and |
| • | a decrease in personnel-related costs of $6.0 million resulting from our Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics. |
Gross profit as a percentage of revenue was 9.8% in the six months ended June 30, 2025 compared to gross loss as a percentage of revenue of 7.9% in the six months ended June 30, 2024 primarily due to:
| • | a decrease in warranty expenses and warranty accruals of approximately 7% associated primarily with a lower cost of materials; |
| • | lower absolute fixed and other production related costs, which were divided this quarter by significantly higher revenue, resulting in lower gross margin of approximately 6%; and |
| • | an improvement in the direct cost of revenue of approximately 5% associated primarily with the increase of US made products and the AMPTC recognized, offset by an increase in costs due to the manufacturing in the U.S., price reductions and a higher portion batteries for PV applications out of our total product mix. |
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 11
Operating Expenses:
Research and Development
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Research and development | $ | 53,386 | $ | 69,276 | $ | (15,890 | ) | (22.9 | )% | $ | 115,383 | $ | 144,627 | $ | (29,244 | ) | (20.2 | )% | ||||||||||||||
Research and development costs decreased by $15.9 million or 22.9%, in the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to:
| • | a decrease in personnel-related costs of $12.5 million resulting from our Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics; |
| • | a decrease in expenses related to consulting and sub-contracting of $1.2 million; and |
| • | a decrease in material consumption in an amount of $1.1 million. |
Research and development costs decreased by $29.2 million or 20.2%, in the six months ended June 30, 2025, compared to the six months ended June 30, 2024, primarily due to:
| • | a decrease in personnel-related costs of $19.7 million resulting from our Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics; |
| • | a decrease in material consumption in an amount of $3.3 million; |
| • | a decrease in depreciation and amortization of $2.5 million; and |
| • | a decrease in expenses related to consulting and sub-contracting of $1.6 million. |
Sales and Marketing
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Sales and marketing | $ | 28,725 | $ | 39,978 | $ | (11,253 | ) | (28.1 | )% | $ | 60,382 | $ | 78,889 | $ | (18,507 | ) | (23.5 | )% | ||||||||||||||
Sales and marketing expenses decreased by $11.3 million, or 28.1%, in the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to:
| • | a decrease in personnel-related costs of $8.6 million resulting from our Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics; and |
| • | a decrease of $1.2 million in marketing expenses. |
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 12
Sales and marketing expenses decreased by $18.5 million, or 23.5%, in the six months ended June 30, 2025, compared to the six months ended June 30, 2024, primarily due to:
| • | a decrease in personnel-related costs of $14.9 million resulting from our Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics; and |
| • | a decrease of $1.1 million in marketing expenses. |
General and Administrative
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
General and administrative | $ | 19,789 | $ | 39,008 | $ | (19,219 | ) | (49.3 | )% | $ | 49,972 | $ | 69,873 | $ | (19,901 | ) | (28.5 | )% | ||||||||||||||
General and administrative expenses decreased by $19.2 million, or 49.3%, in the three months ended June 30, 2025 compared to the three months ended June 30, 2024, primarily due to:
| • | a net reversal of doubtful debt in the amount of $10.0 million in the three months ended June 30, 2025, compared to an expense of $8.7 million, in the three months ended June 30, 2024, mainly related to collection of doubtful debt; and |
| • | a decrease in personnel-related costs of $7.5 million resulting from our Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics. |
These were partially offset by an increase of $8.6 million related to potential legal claims.
General and administrative expenses decreased by $19.9 million, or 28.5%, in the six months ended June 30, 2025, compared to the six months ended June 30, 2024, primarily due to:
| • | a net reversal of doubtful debt in the amount of $18.1 million in the six months ended June 30, 2025, as compared to an expense of $11.7 million, in the six months ended June 30, 2024, mainly related to collection of doubtful debt; and |
| • | a decrease in personnel-related costs of $5.6 million resulting from our Restructuring Plans designed to reduce operating expenses and align our cost structure to current market dynamics; |
These were partially offset by:
| • | an increase of $8.5 million related to potential legal claims; and |
| • | an increase of $8.1 million primarily due to a penalty for postponing the commencement of our campus lease agreement. |
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 13
Other operating expense, net
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Other operating expense, net | $ | 45,724 | $ | 951 | $ | 44,773 | 4,708.0 | % | $ | 42,149 | $ | 3,342 | $ | 38,807 | 1,161.2 | % | ||||||||||||||||
Other operating expenses, net, increased by $44.8 million in the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to:
| • | an increase of $36.7 million related to impairment of held for sale asset; and |
| • | an increase of $18.0 million related to the sale of the PV tracker business line. |
These were partially offset by a gain in the three months ended June 30, 2025 of $10.0 million from sale of property, plant, and equipment compared to a loss of $1.4 million in the three months ended June 30, 2024.
Other operating expenses, net, increased by $38.8 million, in the six months ended June 30, 2025, compared to the six months ended June 30, 2024, primarily due to:
| • | an increase of $36.7 million related to impairment of held for sale asset; and |
| • | an increase of $18.0 million related to the sale of the PV tracker business. |
These were partially offset by:
| • | an increase of $3.1 million in income related to lower than expected discontinuation charges; and |
| • | a gain in the six months ended June 30, 2025 of $9.8 million from sale of property, plant, and equipment compared to a loss of $2.5 million in the six months ended June 30, 2024. |
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 14
Financial income (expense), net
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Financial income (expense), net | $ | (7,323 | ) | $ | (865 | ) | $ | (6,458 | ) | 746.6 | % | $ | 2,745 | $ | (7,929 | ) | $ | 10,674 | (134.6 | )% | ||||||||||||
Financial expense, net increased by $6.5 million in the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to:
| • | $4.3 million expenses in the six months ended June 30, 2025 compared to income of $4.5 million as a result of fluctuations in foreign exchange rates, primarily between the Euro and the NIS against the U.S. dollar; |
| • | a decrease of $3.1 million in interest income related to our marketable securities investments; and |
| • | an increase of $1.9 million in interest expenses related to our Notes 2029. |
These were partially offset by a decrease of $9.2 million due to credit loss related to loans receivable.
Financial income, net was $2.7 million in the six months ended June 30, 2025, compared to financial expenses, net in the amount of $7.9 million in the six months ended June 30, 2024, primarily due to:
| • | $4.4 million income in the six months ended June 30, 2025 compared to expenses of $4.3 million in the six months ended June 30, 2024, as a result of fluctuations in foreign exchange rates, primarily between the Euro and the NIS against the U.S. dollar; and |
| • | a decrease of $12.6 million in credit loss expenses related to loans receivable, |
These were partially offset by:
| • | a decrease of $6.4 million in interest income related to our marketable securities investments; and |
| • | an increase of $3.9 million in interest expenses primarily related to our Notes 2029. |
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 15
Other income
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Other income | $ | 4,017 | $ | 18,551 | $ | (14,534 | ) | (78.3 | )% | $ | 4,165 | $ | 18,551 | $ | (14,386 | ) | (77.5 | )% | ||||||||||||||
Other income decreased by $14.5 million in the three months ended June 30, 2025, compared to the three months ended June 30, 2024, primarily due to:
| • | a decrease of $15.5 million in gain from the repurchase of the 2025 Notes recognized in prior year; and |
| • | a decrease of $2.0 million in realized gain from marketable securities; |
These were partially offset by $4.0 million income from sale of investment in a privately held company.
Other income decreased by $14.4 million in the six months ended June 30, 2025, compared to the six months ended June 30, 2024, primarily due to:
| • | a decrease of $15.5 million in gain from the repurchase of the 2025 Notes recognized in prior year; |
| • | an increase of $2.0 million in realized gain from marketable securities; and |
These were partially offset by $4.0 million income from sale of investment in privately held company.
Tax benefits (income taxes)
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Tax benefits (income taxes) | $ | (5,657 | ) | $ | 12,245 | $ | (17,902 | ) | (146.2 | )% | $ | (11,383 | ) | $ | 35,999 | $ | (47,382 | ) | (131.6 | )% | ||||||||||||
Income taxes were $5.7 million in the three months ended June 30, 2025, compared to tax benefits in the amount of $12.2 million in the three months ended June 30, 2024, primarily due to an increase in our provision for uncertain tax positions and a valuation allowance of the deferred tax assets on our current losses and capital losses, which we do not expect to be able to benefit from it in the foreseeable future.
Income taxes were $11.4 million in the six months ended June 30, 2025, compared to tax benefits in the amount of $36.0 million in the six months ended June 30, 2024, primarily due to an increase in our provision for uncertain tax positions, a valuation allowance of the deferred tax assets on our current losses and capital losses, which we do not expect to be able to benefit from in the foreseeable future, withholding taxes paid on certain intra-group interest payments and additional tax payable as a result of a settlement with the Israeli Tax Authority for tax years 2016-2018.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 16
Net loss from equity method investments
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Net loss from equity method investments | $ | (288 | ) | $ | (567 | ) | $ | 279 | (49.2 | )% | $ | (575 | ) | $ | (863 | ) | $ | 288 | (33.4 | )% | ||||||||||||
Net loss from equity method investments decreased by $0.3 million, or 49.2% in the three months ended June 30, 2025, as compared to the three months ended June 30, 2024.
Net loss from equity method investments decreased by $0.3 million, or 33.4% in the six months ended June 30, 2025, as compared to the six months ended June 30, 2024.
Net loss
Three months ended June 30, 2025 to 2024 | Six months ended June 30, 2025 to 2024 | |||||||||||||||||||||||||||||||
2025 | 2024 | Change | 2025 | 2024 | Change | |||||||||||||||||||||||||||
(In thousands) | ||||||||||||||||||||||||||||||||
Net loss | $ | (124,744 | ) | $ | (130,818 | ) | $ | 6,074 | (4.6 | )% | $ | (223,267 | ) | $ | (288,129 | ) | $ | 64,862 | (22.5 | )% | ||||||||||||
As a result of the factors discussed above, net loss in the three months ended June 30, 2025 and June 30, 2024 was $124.7 million and $130.8 million, respectively.
As a result of the factors discussed above, net loss in the six months ended June 30, 2025 and June 30, 2024 was $223.3 million and $288.1 million respectively.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 17
Liquidity and Capital Resources
The following table shows our cash flows from operating activities, investing activities, and financing activities for the stated periods:
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
(In thousands) | (In thousands) | |||||||||||||||
Net cash provided by (used in) operating activities | $ | (7,799 | ) | $ | (44,772 | ) | $ | 26,024 | $ | (261,791 | ) | |||||
Net cash provided by investing activities | 68,590 | 94,216 | 136,187 | 243,224 | ||||||||||||
Net cash provided by (used in) financing activities | (373 | ) | 303 | (6,610 | ) | (50,684 | ) | |||||||||
Increase (decrease) in cash and cash equivalents | $ | 60,418 | $ | 49,747 | $ | 155,601 | $ | (69,251 | ) | |||||||
As of June 30, 2025, our cash and cash equivalents were $545.2 million. This amount does not include $235.9 million invested in available-for-sale marketable securities, $27.3 million in restricted cash, and $3.5 million invested in deposits and restricted deposits. Our principal uses of cash are for funding our operations, capital expenditures, other working capital requirements, other investments, and the repayment of our Notes 2025. As of June 30, 2025, we have open commitments for capital expenditures in an amount of approximately $18.5 million. These commitments mainly reflect purchases of automated assembly lines and other machinery related to our manufacturing and operations. We also have purchase obligations in the amount of $349.1 million, related to raw materials and commitments for the future manufacturing of our products.
Beginning in the fourth quarter of 2024, we started to sell AMPTCs. We plan to pursue additional tax credit sales in the future.
We believe our cash and cash equivalents, and available-for-sale marketable securities will be sufficient to meet our anticipated cash needs for at least the next 12 months as well as in the longer term, including the self-funding of our capital expenditure, operational commitments and the redemption of our debt.
Operating Activities
Operating cash flows consist primarily of net loss, adjusted for certain non-cash items and changes in assets and liabilities. Cash provided by operating activities was $26.0 million in the six months ended June 30, 2025 compared to cash used in operating activities of $261.8 million in the six months ended June 30, 2024, attributed to a decrease in net loss adjusted for certain non-cash items generated in the six months ended June 30, 2025 compared to the six months ended June 30, 2024, as well as lower operating working capital requirements.
Investing Activities
Investing cash flows consist primarily of capital expenditures, investment in, sales and maturities of available for sale marketable securities, investment and withdrawal of bank deposits and restricted bank deposits, cash used for acquisitions, and disbursements and receipts from collections of loans made by the Company. Cash provided by investing activities decreased by $107.0 million in the six months ended June 30, 2025 compared to the six months ended June 30, 2024, primarily driven by a decrease of $240.0 million in proceeds provided by sales and maturities of available-for-sale marketable securities, and an increase of $17.4 million in purchases of available-for-sale debt investments; these were partially offset by a decrease of $37.5 million in disbursements of loans made by the Company, a decrease of $37.2 million in purchase of property plant and equipment, an increase of $25.9 million in proceeds from loans receivables, a decrease of $25.5 million in the purchase of privately-held companies, a decrease of $10.4 million in cash used for a business combination, a decrease of $10.0 million in purchase of intangible assets, and an increase of $9.3 million in sale of property plant and equipment.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 18
Financing Activities
Financing cash flows consisted primarily of repurchases of our common stock under the share repurchase program, which expired on December 31, 2024, the issuance and partial repurchase of convertible senior notes, and our employee equity incentive plans. Cash used in financing activities in the six months ended June 30, 2025 decreased by $44.1 million compared to the six months ended June 30, 2024, primarily due to a decrease of $262.8 million in cash used for the repurchase of our Notes 2025, a decrease of $50.0 million in cash used in share repurchases, and a decrease of $25.2 million in cash used to purchase the capped call transactions, these were partially offset by a decrease of $293.6 million in cash provided by the issuance of the Notes 2029.
Share Repurchases
On November 1, 2023, we announced the approval by the Board of Directors of a share repurchase program which authorized the repurchase of up to $300 million of the Company’s common stock. Under the share repurchase program, repurchases could be made using a variety of methods, which may have included open market purchases, block trades, privately negotiated transactions, accelerated share repurchase programs and/or a non-discretionary trading plan or other means, including through 10b5-1 trading plans, all in compliance with the rules of the SEC and other applicable legal requirements. The timing, manner, price and amount of any common share repurchases under the share repurchase program were determined by the Company in its discretion and depended on a variety of factors, including legal requirements, price and economic and market conditions. The program did not obligate the Company to acquire any amount of common stock, it could have been suspended, extended, modified, discontinued or terminated at any time at the Company’s discretion without prior notice, and expired on December 31, 2024. The Company repurchased 753,364 shares under the program.
During the six months ended June 30, 2024, the Company repurchased 753,364 shares of common stock from the open market at an average cost of $66.79 per share for a total of $50.3 million.
Convertible Senior Notes
On June 28, 2024, we sold an aggregate principal amount of $300 million of 2.25% convertible senior notes due in 2029 in a transaction exempt from registration pursuant to Rule 144A and Regulation S under the Securities Act. The net proceeds from the offering of the Notes 2029 were approximately $293.2 million, after deducting fees and estimated expenses. Separately, we have entered into capped call transactions. We used approximately $25.2 million of the net proceeds from this offering to pay the cost of the capped call transactions and approximately $267.9 million of the net proceeds from this offering to repurchase $285.0 million principal amount of its outstanding 0.000% convertible notes due 2025. As a result of the repurchase of Notes 2025, we recognized a gain of $15.5 million which was recorded under other income. We intend to use the remainder of the net proceeds from the offering for general corporate purposes.
On July 8, 2024, we sold an aggregate principal amount of $37 million of the Notes 2029. The Notes 2029 were sold pursuant to the Initial Purchasers’ exercise of the option granted by the Company to the Initial Purchasers to purchase additional Notes 2029, as described above in Note 11, “Convertible Senior Notes.”
In March 2025 the Company repurchased $5.2 million principal amount of its Notes 2025. The Company recorded a net gain of $146 thousands under other income, from this repurchase.
After such repurchases, an aggregate of $342.2 million principal amount of the Notes 2025 remained outstanding. The Notes 2025 mature on September 15, 2025, and we expect that the holders will not convert prior to maturity. We intend to repay the principal amount of the Notes 2025 from cash on hand.
Critical Accounting Policies and Significant Management Estimates
Management believes that there have been no significant changes during the six months ended June 30, 2025 to the items that we disclosed as our critical accounting policies and estimates in MD&A in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, except as mentioned in Note 1, “General” (if any).
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 19
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to market risk in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates, customer concentrations, interest rates and commodity prices. We do not hold or issue financial instruments for trading purposes.
Foreign Currency Exchange Risk
Approximately 34.1% and 48.3% of our revenues for the six months ended June 30, 2025, and June 30, 2024, respectively, were earned in non-U.S. dollar denominated currencies other than the U.S. dollar, principally the Euro. Our expenses are generally denominated in the currencies in which our operations are located, primarily the U.S. dollar, NIS, and Euro. Our NIS denominated expenses consist primarily of personnel and overhead costs. Our consolidated results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates and may be adversely affected in the future due to changes in foreign exchange rates. A hypothetical 10% change in foreign currency exchange rates between the Euro and the U.S. dollar would increase or decrease our net income by $11.4 million for the six months ended June 30, 2025. A hypothetical 10% change in foreign currency exchange rates between NIS and the U.S. dollar would increase or decrease our net income by $19.8 million for the six months ended June 30, 2025.
For purposes of our consolidated financial statements, local currency assets and liabilities are translated at the rate of exchange to the U.S. dollar on the balance sheet date, and local currency revenues and expenses are translated at the exchange rate as of the date of the transaction or at the average exchange rate to the U.S. dollar during the reporting period.
To date, we have used derivative financial instruments, specifically foreign currency forward contracts and put and call options, to manage exposure to foreign currency risks by hedging portions of the anticipated payroll payments denominated in NIS. These derivative instruments are designated as cash flow hedges.
In addition, from time to time we enter into derivative financial instruments to hedge the Company’s exposure to currencies other than the U.S. dollar, mainly forward contracts to sell Euro for U.S. dollars. These derivative instruments are not designated as cash flow hedges.
Concentrations of Major Customers
Our trade accounts receivables potentially expose us to a concentration of credit risk with our major customers. As of June 30, 2025, one major customer accounted for approximately 25.3% of our consolidated trade receivables, net balance. As of June 30, 2024, two major customers jointly accounted for approximately 25.3% of our consolidated trade receivables, net balance. For the three months ended June 30, 2025, three major customers accounted for approximately 44.6% of our total revenues. For the three months ended June 30, 2024, one major customer accounted for approximately 11.3% of our total revenues. For the six months ended June 30, 2025 two major customers accounted for approximately 24.0% of our total revenues. For the six months ended June 30, 2024 no single major customer contributed more than 10% of our total revenues.
Commodity Price Risk
We are subject to risk from fluctuating market prices of certain commodity raw materials which are used in our products, including Copper, Lithium, Nickel and Cobalt. Prices of these raw materials may be affected by supply restrictions or other market factors from time to time, and we do not enter into hedging arrangements to mitigate commodity risk. Significant price changes for these raw materials could reduce our operating margins if we are unable to recover such increases from our customers, and could harm our business, financial condition, and results of operations.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 20
Item 4. Controls and Procedures.
Disclosure Controls and Procedures
Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of June 30, 2025. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.
Based on that evaluation, our chief executive officer and chief financial officer concluded, as of June 30, 2025, that our disclosure controls and procedures were effective and operating to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and to provide reasonable assurance that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
We substantially completed the implementation of our new ERP system during the fiscal quarter ended June 30, 2025. We are performing our post-implementation activities. The implementation of that ERP system is expected to, among other things, improve user access security and automate a number of accounting, back office and reporting processes and activities, thereby decreasing the amount of manual processes previously required. The implementation resulted in, and the post-implementation activities may result in, changes to certain of our processes and procedures. These changes have been and will continue to be subject to our evaluation of the operating effectiveness of internal controls over financial reporting. Except for the implementation of the new ERP system as described in this paragraph, there have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the quarter ended June 30, 2025, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 21
PART II. OTHER INFORMATION.
ITEM 1. Legal Proceedings
In the normal course of business, we may from time to time be named as a party to various legal claims, actions and complaints (including as a result of initiating such legal claims, action or complaints on behalf of the Company), including the matters described in Note 14 – “Commitments and Contingent Liabilities” to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q and in Item 3 – “Legal Proceedings” of our Annual Report on Form 10-K for the period ended December 31, 2024. It is impossible to predict with certainty whether any resulting liability from any such legal claims, actions or complaints would have a material adverse effect on our financial position, results of operations or cash flows.
ITEM 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the risks set forth below and the risk factors as described in Part I, Item 1A, “Risk Factors”, in our Annual Report on Form 10-K for the year ended December 31, 2024. Other than the risk factors set forth below, there have been no material changes to the risk factors previously disclosed in the 2024 Form 10-K.
Changes in tax law, tax treaties, and regulations or the interpretation of them, including the Inflation Reduction Act and the One Big Beautiful Bill Act could reduce demand for our products, eliminate tax credits available to us and to our customers, harm our business and otherwise adversely impact our results of operations.
National, state and local government bodies in many countries, including the United States, have provided incentives in the form of rebates, tax credits, tax incentives and others to manufacturers, system owners, distributors and installers of solar PV systems and battery energy storage systems.
In August 2022, the IRA was signed into federal law. The IRA provides for, among other things, certain incentives, including certain tax credits for solar energy, that are significant to the Company and its U.S. based customers. On July 4, 2025, the OBBB was enacted into law, introducing amendments to clean energy tax credits contained in the IRA. The OBBB accelerates the phase-out timeline for certain credits and imposes new eligibility criteria.
The Company has invested significant resources in establishing our manufacturing presence in the U.S. to benefit from the incentives available under the IRA, including incentives and tax credits available to us for manufacturing in the U.S. and credits and incentives available to certain of our US customers. The Company established manufacturing capabilities in the U.S. in 2023 and further expanded such capabilities in 2024 and 2025. Moreover, we incorporate into our planning and agreements with our customers and suppliers certain assumptions regarding U.S. tax incentives. Material changes thereto could adversely affect our revenue, our eligibility for certain tax credits, tax credits available to our customers, competitiveness and demand for our products and our financial condition.
Section 45X of the Code, as enacted by the IRA, offers Advanced Manufacturing Production Tax Credits (“AMPTC”s) that incentivize the manufacturing of eligible components within the U.S. Of particular relevance to the Company are the tax credits that we generate as a result of rules concerning the qualification and measurement of AMPTCs to Residential Inverters, Commercial Inverters and DC-Optimized Inverter Systems that we manufacture in the United States. The OBBB does not shorten the term of such Section 45X credits.
Among other changes, the OBBB shortens the term of the investment tax credit and production tax credit under Section 48E and 45Y of the Code, available to the Company’s customers, who are engaged in third-party ownership (“TPO”) models, such as residential solar leases and power purchase agreements, and commercial solar customers and developers, shortening the end date from 2034 to 2027. The OBBB also includes a 12-month window in which such customers can begin construction, giving them four years to complete their projects. Projects begun after twelve months from enactment of the OBBB must be placed in service by December 31, 2027, to receive the credit. The OBBB also amends the domestic content bonus credit rules for Section 48E projects: Projects commencing construction after June 16, 2025 must meet a 45% domestic cost threshold, up from 40%, and the threshold thereafter increases on an annual basis until 2029. The OBBB eliminates the individual residential tax credit under Section 25D of the Code at the end of 2025. These changes may negatively impact the eligibility of our customers and individuals to obtain tax credits, which may negatively affect the overall demand for our products.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 22
The OBBB has also introduced new Foreign Entity of Concern (“FEOC”) requirements for Sections 45X, 45Y, and 48E of the Code. These restrictions will require threshold percentages of non-FEOC material that increase over time, beginning in 2026. On July 7, 2025, the President issued an Executive Order titled “Ending Market Distorting Subsidies for Unreliable, Foreign Controlled Energy Sources.” This directive instructs the U.S. Department of the Treasury to issue revised guidance within 45 days. There are multiple areas of the OBBB that require the U.S. Treasury Department to provide guidance, and such guidance may impact beginning of construction requirements applicable to our customers or create challenges for the Company or its customers to meet the FEOC requirements. If we are unable to meet the requirements this may adversely affect our revenue, our or our customers eligibility to obtain certain tax credits, the overall demand for our products, our results of operations and cash flows.
Any unfavorable regulatory treatment, or guidance, expiration of or changes to the benefits made available, which we relied upon in structuring certain projects and investments, or any adverse impacts on our ability to ramp up production in the U.S. in a timely manner to benefit from the incentives available under the IRA and the OBBB, could adversely impact our business and financial condition.
Changes in the global trade environment, including the United States trade environment, such as the increase or imposition of import tariffs, could adversely affect the amount or timing of our revenue, results of operations or cash flows.
The United States has recently imposed significant new tariffs on nearly all products and components imported into the United States and could propose additional tariffs or increases to those already in place. We have relocated our contract manufacturing to the United States, where we manufacture the vast bulk of our products. We continue to manufacture a minor portion of our products in Israel, at our Sella 1 facility. However, certain components and subcomponents necessary for our products are currently required to be imported from outside the U.S. It is unknown whether and to what extent these tariffs will remain in place or if other new laws or regulations will be adopted. In addition, retaliatory tariffs may be imposed on products exported from the United States to other countries in which we sell our products. Due to broad uncertainty regarding the breadth, timing and extent of any regulatory changes related to trade, in the United States or abroad, we cannot predict the impact, if any, that these changes could have to our business, financial condition, ability to compete, and the results of operations.
It is unknown what effect any such new tariffs or retaliatory actions will have on the solar industry and our customers. The resulting environment of escalating trade tension, retaliatory trade tension, or other trade actions, restrictive measures, additional trade restrictions, or barriers, if implemented on a broader range of products or components from outside the United States, or with respect to products shipped from the United States, could harm our ability to obtain necessary product components or to sell our products at prices customers are willing to pay, which could have a material adverse effect on our business, prospects, results of operations and cash flows.
Furthermore, if the price of solar power systems in the United States increases, as well as the cost of manufacturing our products in the United States, the use of solar power systems could become less economically feasible and could reduce our gross margins or reduce the demand of solar power systems manufactured and sold, which in turn may decrease demand for our products. Additionally, existing or future tariffs could negatively affect key partners, suppliers and manufacturers. Such outcomes could adversely affect the amount or timing of our revenue, results of operations or cash flows, and continuing uncertainty could cause sales volatility, price fluctuations or supply shortages or cause our customers to advance or delay their purchase of our products. It is difficult to predict what further trade-related actions the U.S. and other governments may take, which may include additional or increased tariffs and trade restrictions, and we may be unable to quickly and effectively react to such actions. As additional new tariffs, legislation and/or regulations are implemented, or if existing trade agreements are renegotiated or if affected countries take retaliatory trade actions, such changes could have a material adverse effect on our business, financial condition, results of operations or cash flows.
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None
ITEM 3. Defaults upon Senior Securities.
None
ITEM 4. Mine Safety Disclosures
Not applicable.
ITEM 5. Other Information
None.
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 23
ITEM 6. Exhibits
Index to Exhibits
Exhibit No. | Description | Incorporation by Reference | ||
10.1† | Employment Agreement, dated January 1, 2025 between SolarEdge Technologies, Ltd. and Daniel Huber | Filed with this report. | ||
31.1 | Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and15d-14(a) of the Securities Exchange Act of 1934, as amended | Filed with this report. | ||
31.2 | Certification of Chief Financial Officer Pursuant to Rules 13a-14(a) and15d-14(a) of the Securities Exchange Act of 1934, as amended | Filed with this report. | ||
32.1 | Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Furnished with this report. | ||
32.2 | Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Furnished with this report. | ||
101 | The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, (vi) Notes to Condensed Consolidated Financial Statements, and (vii) part II, Item 5(c) | |||
104 | The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 formatted in Inline XBRL | Included in Exhibit 101 |
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 24
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: August 7, 2025
/s/ Shuki Nir | |
Shuki Nir | |
Chief Executive Officer (Principal Executive Officer) |
Date: August 7, 2025
/s/ Asaf Alperovitz | |
Asaf Alperovitz | |
Chief Financial Officer (Principal Financial Officer) |
SOLAREDGE TECHNOLOGIES INC. | 2025 Form 10-Q | 25
Source:
FAQ
What did AVITA Medical (RCEL) announce in its August 7 2025 8-K?
The company amended its credit agreement, lowering revenue covenants and issuing 400,000 common shares to its lenders.
How have the revenue covenants changed for RCEL?
They are now $73 m for Q3-25, $77 m for Q4-25, $90 m for Q1-26 and $103 m for Q2-26, with $115 m thereafter.
Will the amendment dilute existing shareholders?
Yes. AVITA will issue 400,000 registered shares, equivalent to roughly 1鈥�2 % dilution depending on the share count.
Does the 8-K include AVITA鈥檚 Q2-25 financial results?
No. It only states that results were released separately in Exhibit 99.1; figures are not included in the filing text.
Why did AVITA Medical issue shares instead of paying cash?
The filing does not specify, but issuing equity preserves cash while compensating lenders for covenant relief.
Solaredge Technologies Inc
NASDAQ:SEDG
SEDG Rankings
SEDG Latest News
Aug 5, 2025
SolarEdge Announces Strategic Partnership with Schaeffler for EV Charging Infrastructure
Jul 30, 2025
SolarEdge and Solar Landscape Sign Strategic Agreement for American-Manufactured SolarEdge Technology
SEDG Latest SEC Filings
SEDG Stock Data
1.54B
58.33M
1.21%
97.06%
25.07%
Solar
Semiconductors & Related Devices
Israel
HERZILIYA PITUACH